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Abstract
Haemonchus contortus antigen identification and use of tropomyosin in ovine
vaccine development
Brynnan Russ
Globally, the small ruminant industry loses hundreds of millions of dollars due to
parasitism by the gastrointestinal nematode Haemonchus contortus. This parasite feeds
on blood in the host’s abomasum leading to disease including anemia, hypoproteinemia,
lethargy, and death. There have been exhaustive efforts to manage this parasite including
different management applications, anthelmintic treatment, and now integration of
resistance genetics into a flock. Like antibiotics, overuse of anthelmintics has led to
resistance of H. contortus to these drugs. Therefore, other methods of control are the
main focuses of many research initiatives. St. Croix are a resistant breed of sheep that
mount a Th2 immune response to third stage larvae (L3), preventing establishment of the
parasite. Suffolk are susceptible to infection. In these studies, antibody from St. Croix and
Suffolk were used to screen for H. contortus protein-sheep antibody binding that may
contribute to the St. Croix immune response. This was carried out using immunoblotting
technique and identified a 35 kDa H. contortus L3 protein bound by St. Croix serum, but
not by Suffolk serum. This protein was identified via Mass Spec as tropomyosin domain
containing protein. Tropomyosin has been used in several parasite vaccine trials and is
also the main allergen of several arthropods including shrimp and cockroaches. These
studies led to the continued investigation of tropomyosin as a putative vaccine candidate
in sheep. Peptides were selected and synthesized based on University of Nebraska
epitope prediction software and from a study that used tropomyosin peptides in
proliferation assays of CD4+ cells isolated from patients allergic to shrimp. After receiving
these peptides, enzyme linked immunosorbent assays (ELISA) were performed to
determine if there was a breed or infection effect on antibody specificity to these peptides.
There were no differences in antibody binding between naïve or primed (previously
infected), St. Croix or Suffolk (Nebraska: P= 0.3889, 54: P=0.1674, 66: P= 0.4110, 80:
P= 0.0527, 81: P= 0.3878). The second set of peptides was selected from the results of
an epitope mapping experiment using overlapping Hc tropomyosin peptides screened
with primed St. Croix antibody. Four peptides were selected from this experiment and
were synthesized, a set with and without conjugation to keyhole limpet hemocyanin (KLH)
for a vaccine trial. ELISA were performed with these peptides and showed no difference
between groups (Peptide 1: P= 0.2501, Peptide 2: P= 0.0732, Peptide 3: P= 0.0900,
Peptide 4: P= 0.3250). However, results based on the epitope mapping experiment
provided better expectations for these peptides in a vaccine trial. The vaccine trial 25
weeks and included 4 groups- 1) vaccinated (peptide cocktail of 62.5 µg of each peptide
+ Montanide ISA 61 VG adjuvant), 2) adjuvant only, 3) infection only, and 4) naïve.
Vaccinated and adjuvant only received an initial vaccination and a booster 4 weeks later.
Six weeks later, animals in groups 1, 2, and 3 were challenged with 10,000 L3 H.
contortus. The animals were dewormed 7 weeks later and rested for two weeks followed

by a second challenge of 10,000 L3. Five weeks later, all animals were sacrificed. There
were no differences in weekly or final infection parameters (fecal egg count: P= 0.8744,
packed cell volume: P= 0.7532, adult worm burden: P=0.8189). However, the vaccinated
group produced specific antibody to the peptide cocktail based on ELISA results. Gene
expression revealed an adjuvant effect – increasing il17a expression. Although the
vaccine was not protective, this experiment showed that Suffolk are able to respond to a
vaccine and produce specific antibody to specific peptides. These experiments also
provide a roadmap for future H. contortus vaccine development experiments.
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Common Abbreviations
APC = antigen presenting cell
CD= clusters of differentiation
ConA= Concanavalin A
ELISA = enzyme-linked immunosorbent assay
FEC = fecal egg count
Hc = Haemonchus contortus
HcLA = Haemonchus contortus larval antigen
IFNγ = interferon gamma
Ig = Immunoglobulin
IL- = interleukin
JAK = Janus Kinase
KLH= keyhole limpet hemocyanin
L3 = infective third stage
MHC= major histocompatibility complex
PBMC = peripheral blood mononuclear cells
PCV = packed cell volume RT = room temperature
STAT = signal transducer and activator of transduction
STC = St. Croix sheep
SUF = Suffolk sheep
TEM= transmission electron microscopy
Th1 = T helper type 1
Th2 = T helper type 2
TPM= tropomyosin
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Chapter 1: Literature Review
Haemonchus contortus
Lifecycle and pathogenic effects
Haemonchus contortus (Hc) is a hematophagic gastrointestinal nematode that
affects small ruminants and has a direct lifecycle with no intermediate host. Adult females
shed eggs while inhabiting the hosts abomasum and eggs enter the environment via host
feces. After hatching, first stage larvae require approximately 7 days in favorable
environmental conditions to develop into third stage larvae (HcL3). Third stage larvae
travel up blades of grass in dew droplets where they are consumed by animals. L3 have
a cuticle, that protects from environmental factors and maintains internal osmotic
pressure. Once consumed by sheep, L3 travel with digesta to the abomasum where they
shed their cuticles and molt, becoming blood-feeding fourth stage larvae (L4). L4 then
develop into adults that reproduce sexually and release their eggs for continuation of the
life cycle. Hc late stage larvae (L4) and adults use a buccal lancet to pierce the abomasal
mucosa to produce a blood flow for feeding (Weise, 1977).
Female adult worms consume up to 0.05ml of blood per day (Clark et al., 1962)with an adult worm burden of 1000, this leads to upwards of 50 ml of blood loss per day.
With an established infection of H. contortus, adult sheep can lose up to 1/10 erythrocyte
volume per day and lamb can lose up to 1/4 erythrocyte volume per day (Georgi and
Whitlock, 1967). Blood loss caused by Hc often leads to anemia. Blood vessels
throughout the body become leaky to replace fluid loss and leads to hypoproteinemia and
edema. Disease caused by the gastrointestinal parasite, Hc, is a leading source of
economic loss in small ruminant industries worldwide. Australia, alone, in 2016 had over
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300 million USD in losses due to Hc infection (Emery et al., 2016). Costs include
treatment with anthelmintics, increased feed and time to raise the animals, and animal
death. In 2015, the USDA estimated that 8.6% of sheep and lamb deaths in the United
States

were

caused

by

internal

parasites,

including

Hc

(https://www.aphis.usda.gov/animal_health/nahms/sheep/downloads/sheepdeath/Shee
pDeathLoss2015.pdf).
Methods of Control
One of the most important issues surrounding Hc is anthelmintic resistance.
Resistance to anthelmintics has been reported as early as 1960 to classes including:
Benzimidazoles, Organophosphates, and Imidazothiazoles (Drudge et al., 1964; Green
et al., 1981). Factors that contribute to development anthelmintic resistance are high
heritability and diversity of alleles associated with resistance, high fecundity of female
adults (one female Hc can release up to 5000 eggs per day), and improper use of the
anthelmintic treatments by producers (Silvestre and Humbert, 2002). The newest class
of anthelmintic, monepantel, was released for use in 2009; by 2015 there were already
two cases of resistance reported (Mederos et al., 2014; Van den Brom et al., 2015).
Another concern surrounding drug resistance is multi-drug resistance strains of Hc
leading to lack of effective chemical treatment options available to producers.
To mitigate development of anthelmintic resistance, the FAMACHA™ scoring
system was developed. Using FAMACHA™ to selectively deworm provides a refuge for
drug-susceptible genes to be maintained. FAMACHA™ scoring utilizes the paleness of
the conjunctivae as an indicator for anemia, with a score of 1 being red and healthy and
5 being pale and fatally anemic (Malan and Van Wyk, 1992). This allows producers to
2

select individuals that are worst off for treatment with anthelmintic drugs, reducing
treatment and lowering instance of resistance in Hc (Van Wyk and Bath, 2002;
Wolstenholme et al., 2004; Ejlertsen et al., 2006).
Other alternative methods to help reduce the impact of Hc includes rotational
grazing. Rotational grazing involves frequent movement of animals to different pastures
in efforts to reduce exposure to larvae and limit adult parasite infection. The frequency of
switching pastures depends on the climate and season as well as land availability and
nutrition of the land that is available (Barger et al., 1994; Burke et al., 2009). In warmer,
humid climates L3 are more likely to survive in the pasture, leading to more regular
rotations. However, in cooler, dryer climates, the frequency of rotating pastures is
reduced.
Alternative methods of controlling Hc also include copper oxide wire particle bolus
administration, nutritional management such as increasing protein availability, and
grazing forages with condensed tannins (Bang et al., 1990; Steel, 2003; Burke and Miller,
2006; Lange et al., 2006; Heckendorn et al., 2007; Manolaraki et al., 2010; Vatta et al.,
2012; Martínez-Ortíz-de-Montellano et al., 2013). While these methods are useful, there
is one that continues to gain great interest and that is a genetic approach.
Selection for parasite resistance is one of two genetic approaches to manage the
impact of Hc on economical sheep production. By identifying within breed variation in
FEC, producers can incorporate parasite resistance in their selection strategy. This
approach has been shown to impact parasite resistance on a flock-wide basis as best
demonstrated by selection within the Katahdin breed. Estimated Breeding Values (EBV)
is an estimate of an animals’ genetic merit for a trait and is influenced by individual
3

performance and that of relatives. By calculating an EBV for FEC reduction (FECR), the
National Sheep Improvement Program (NSIP) has shown that US flock average FEC EBV
has decreased from +20 in 2000 to -45 in 2016 (NSIP, 2016). These data indicate that
significant, and reasonably rapid progress can be made within breed when selection
emphasis is placed on parasite resistance which also supports data that indicate
moderate heritability for this trait (Notter et al., 2018). While this type of selection has
worked for Katahdin breeders, availability of this EBV in other breeds is scarce and will
limit producer incorporation of this selection strategy.
The Katahdin Hair Sheep is currently the most popular sheep breed in the US
based on annual new registrations but also due to producers experiencing more parasite
problems nationwide. The breed that has contributed to parasite resistance in Katahdin
Sheep is the St. Croix. This breed was developed in the Caribbean islands after their
ancestors were brought from West Africa in the 16th century (Thomas, 1991). Some of
the benefits of the St. Croix breed include: low maintenance cost, ewe productivity is high,
lamb survival rate is high, and they are known to have high resistance to internal parasites
(Gamble and Zajac, 1992; Wildeus, 1997). These sheep adapt well in warm, humid
environments such as the Southeastern, United States unlike other breeds such as
Suffolk. They also can adapt to the cold by growing winter coats when raised in colder
climates (Ward, 2017). However, St. Croix average daily gain and quality of meat is lower
compared to wool breeds, such as Suffolk. Another downfall of the St. Croix is their small
carcass size; mature rams on average weigh 90 kg, while mature ewes weigh 68 kg. In a
production system, St. Croix ewes can play an important role to pass on hardiness when
crossed with more heavily muscled breeds, such as the Dorper (Burke et al., 2003).
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Despite these flaws, this breed has worked to improve our knowledge of immune
response to Hc infection.
Material reviewed in this section have illustrated that strategies meant to mitigate
influence of parasitism on production must be those that incorporate a systems approach.
This approach should address grazing method, selective deworming, nutritional
supplementation and most of all genetic selection. Incorporating all of these management
practices on top of managing everything else is a complicated task, therefore, a simpler
approach is needed that would not absolve producers of their managerial duties but rather
make their life just a bit easier. Thus, development of an effective, easy-to-use vaccine
against Hc would be a desired approach to augment control strategies already in place.
However, before this can start, knowledge of ovine immune response to Hc is critical.

5

Immune Response to Haemonchus contortus
The immune system and immune response are key to protecting the body against
pathogens. After infection, part of the immune response called the innate response is
mounted and is largely unspecific. Cells associated with the innate immune response
include neutrophils, eosinophils, monocytes, and in sheep, both γδ T cells and epithelial
cells also contribute. Innate immunity is important for mounting an initial response to
pathogens as well as for recruiting other cells to the site of infection for further
development . These other cells include adaptive immune cells such as T cells and B
cells. The adaptive immune response is developed specifically to the pathogen and
ultimately helps clear it from the body. The adaptive immune response is also imperative
in developing immune “memory” to prevent or reduce the impact of future infections of
the same pathogen.
Innate Immunity
Role of Neutrophils:
Infective, HcL3 elicit immune responses as early as 3 days after infection. This
delay in responsiveness reflects travel time to the abomasum which is the tissue niche
for this parasitic infection of Hc (Adams, 1982; Balic et al., 2002). Early innate cell influx
to the abomasum is a characteristic immune response expressed by parasite resistant
sheep but not observed in parasite susceptible sheep until days later (Bowdridge et al.,
2015). Authors of this paper found that innate cell influx is also associated with reduced
larval burden. Neutrophils were found to exponentially increase from day 3 to day 7 after
infection in parasite-resistant sheep, where no change in neutrophil influx was observed
in parasite susceptible sheep.
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The role of neutrophils in the context of helminth infection is curious because they
are traditionally associated with bacterial or viral responses and have a role in
phagocytosis. Recent studies revealed new roles for neutrophils, particularly in memory
responses, where these cells exhibit a different phenotype after challenge infection with
the nematode, Nippostrongylus brasiliensis in mice. The authors of this study reported
that neutrophils adopted an “N2” phenotype, upregulating Th2-associated cytokine genes
IL-13, IL-33, Igf1, Retnla (RELMα) and Chi3l3 (Ym1) (Chen et al., 2014). Recent sheep
studies revealed that neutrophils from St. Croix sheep produce IL-4 quickly in vitro in
response to HcL3

antigen (larval homogenate) but not to adult antigen (adult

homogenate) (Middleton et al., 2020). These data support a role for neutrophils as an
early source for IL-4 during Hc infection in sheep. However, de novo cytokine synthesis
is not the only feature of these cells.
Current studies evaluating the role of neutrophils in sheep have revealed that these
cells preferentially produce extracellular traps (NETs) in culture with L3 H. contortus,
when derived from parasite-resistant sheep. The authors went on to demonstrate that
NETs inhibit larval mobility and lead to larval clumping, presumably facilitating larval
expulsion (Garza et al., 2018). This study also described how neutrophils from parasiteresistant sheep have a different type of NET activity called vital netosis, where neutrophils
that have ejected cellular DNA are also still alive and have not begun apoptosis. Whereas
neutrophils from Suffolk sheep experience classic netosis where once NETs are formed
the cells are actively engaged in apoptosis. These data, coupled with early influx of
neutrophils after Hc infection support a key role for neutrophils in early immune response
(Bowdridge et al., 2013).
7

Role of Eosinophils
Eosinophils respond to alarmins and have been implemented in mounting a
protective immune response to Hc. Helminth studies have shown that IL-5 is imperative
for eosinophil influx and differentiation (Coffman et al., 1989). Using Trichostrongylus
colubriformis as a model for GI helminth infection in sheep, Bao et al., 1996 showed an
upregulation of IL-5 gene expression in the small intestine lamina propria, mesenteric
lymph node, and Peyer’s patches of sheep (Bao et al., 1996).
In vitro, eosinophils primed with serum, complement, and IL-5 were able to directly
bind and pull the cuticle away from the larval body. This binding caused larvae to remain
immobile for 3 day and authors reported that these larvae were dead (Rainbird et al.,
1998). Another role eosinophils play is the release of granules that damage different life
stages of parasites, making them more susceptible to other facets of the immune
response. Studies determining the composition of human eosinophil granules have
identified charcot-leyden crystals, or galectin-10 as one of the granule proteins released
(Ackerman et al., 2002). In sheep, the orthologue for eosinophil-released galectin-10 is
galectin-14 (Young et al., 2009; Robinson et al., 2011a) which is released by eosinophils
and is found in sheep GI mucosal lining at rest and during Hc infection (Young et al.,
2009; Robinson et al., 2011a). While the mechanism is yet to be elucidated, galectin-14
levels were negatively correlated with final worm burden, thus, indicating a potential role
for eosinophil-released galectin-14 in reducing Hc infection (Robinson et al., 2011a).
Galectin-11 is also found in sheep GI epithelial lining during infection, and may also be
released by eosinophils (Cummings and Liu, 2009; Preston et al., 2015). Galectin-11 is
hypothesized to make the GI lining stickier, inhibiting free movement of the parasite and

8

increasing larval expulsion. An in vitro study showed Galectin-11 bound to Hc L4 and
adult pharynx regions but not L3 and prevented further development of the parasite.

Role of γδ T cells and Epithelial Cells
T cell receptor phenotypes include αβ heterodimers or γδ heterodimers. While αβ
T cells are considered adaptive cells, γδ T cells play a unique role in straddling the innate
and adaptive immune responses. Most mammalian species see reductions of γδ T cell
concentrations as they age, sheep and cattle maintain high concentrations of γδ T cells
into adulthood. Concentrations as high as 50% of the T cell population have been reported
in sheep (Evans et al., 1994). Rather than requiring external signals for maturation, γδ T
cells can leave the thymus with low-specificity TCRs able to bind and act against
pathogens. In humans, there are reports of γδ T cell receptors recognizing pathogen
associated molecular patterns (Holtmeier and Kabelitz, 2005; Parker and Ciofani, 2020).
Young ruminants have higher concentration of γδ T cells than  T cells,
presumably to allow development of an undeveloped immune system. The functions of
γδ T cells include antigen presentation to CD4+ cells, cytokine productions, and effectors
as cytotoxic cells (Guerra-Maupome et al., 2019). To elucidate the role of γδ T cells
during helminth infection, anti-WC1+ antibody was administered to Canaria Hair sheep to
deplete γδ T cells and determine the effect on adult worms. Without WC1 + γδ T cells,
female worms grew longer and had higher number of eggs in utero. These results
illustrate WC1+ γδ T cell roles in reducing adult female fecundity and thus affecting their
ability to continue their life cycle (Hernández et al., 2017).
All life stages of Hc are large pathogens, particularly when compared to bacteria
or viruses; HcL3 – the smallest of the infective life stages- measures an average of 750
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µm long (Anderson, 1995). All life stages also produce and excrete molecules known as
excretory/secretory products (E/S). Parasites elicit unique immune responses due to
these multiple factors- size of the pathogen, E/S products, and antigens associated with
the worm itself. The innate immune response is responsible for initiating the response
against HcL3 and early prevention of establishment. In addition, all infective life stages of
H. contortus must avoid being swept away by gastrointestinal peristalsis by constant
movement, leading to epithelia and mucosal disturbance. These cells then release
cytokines, alerting the immune system to the presence of large pathogens. During
infection with Trichostrongylus colubriformis, another sheep GI nematode, sheep
epithelial cells released alarmin cytokines IL-33, IL-25 and thymic stromal lymphopoietin
(TSLP), leading to the recruitment of innate cells to the site of infection to initiate polarize
the immune response towards a Th2 response (Humphreys et al., 2008; Wang et al.,
2011; Andronicos et al., 2012; Lopes et al., 2015; Maizels and McSorley, 2016).

Role of Monocytes
Monocytes are plastic cells and can differentiate into either macrophages or
dendritic cells. Macrophages and dendritic cells are known as bridges between innate
and adaptive immune. Dendritic cells’ main role is to collect antigen material, process it
and present to adaptive immune cells via MHC (Chan et al., 2002). Depending on its
derivation and local cytokine influence, macrophages have different functions. One
function is to maintain tissue through phagocytosis of dead, infected, and dying cells
(Gordon & Martinez, 2010; Mantovani et al., 2013). Macrophages also mediate
inflammation through cytokine production and shifting profiles when needed. In a 15-hour
time period, isolated monocytes from either St. Croix or susceptible Suffolk, cultured with
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Hc L3 in vitro, showed different abilities to shift their immune profiles. St. Croix monocytes
were able to shift from an inflammatory “M1” cytokine profile to an anti-inflammatory “M2”
profile. However, Suffolk monocytes maintained M1 profiles, illustrating an ability of some
monocytes to be “plastic” in their development (Shepherd, 2019). Monocytes act as a
bridge between the innate and adaptive immune responses through presentation of
antigen to T and B cells, eliciting a specific immune response.
Adaptive immune response
T cells
T cells develop in the thymus and either express αβ T cell receptors (TCR) or γδ t
cell receptors. γδ T cells are able to leave the thymus as effector cells, while αβ T cell
leave the thymus as naïve cells (Parker and Ciofani, 2020). As discussed earlier, γδ T
cells act as both innate and adaptive cells. Alternatively, αβ T cells require antigen to be
presented to them through their TCR to mature. Antigen presenting cells deliver the
processed antigen as peptide via MHC class I or class II, depending on the coreceptor
present on the surface of the T cell- CD8 or CD4, respectively. CD8+ T cells are also
known as cytotoxic T cells; their main function is to target infected cells and program them
for apoptosis via transfer of cytotoxic proteins in lysosomes. Another function of CD8+ T
cells is direct killing of pathogens including bacteria, viruses and parasites.
CD4+ cells are also referred to as T helper cells. Depending on the antigen
presented to the cell and cytokine environment, naïve CD4+ T cells can develop into many
population subsets. Janus kinase-signal transducer and activator of transcription (JAKSTAT) pathways play important roles in T helper cell polarization (Renauld, 2003).
Cytokines surrounding the naïve T helper cell binds the external portion of the
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transmembrane protein, JAK. After the cytokine binds, JAK dimerizes leading
phosphorylation of STAT within the cytoplasm of the cell. Phosphorylation of different
STAT proteins leads to transcription of polarizing genes. When activated, T helper cells
generally induce a positive feedback loop to maintain their phenotype and maintain the
cytokine environment.
T helper type 1 (Th1) cells are stimulated after the transcription factor, T-bet is
activated via STAT1 and STAT4 which are activated by IFN-γ and IL-12. Th1 cells then
produce IFN-γ themselves, leading to a pro-inflammatory immune response. Th2 cells
are activated after IL-4 binds its JAK protein, phosphorylating STAT6. Th2 cells produce
IL-4, IL-5 and IL-13, inducing an anti-parasitic immune response (O’Shea and Murray,
2008). Th17 cells are activates via STAT3 and induce IL-17 expression. The role of Th17
cells s still being elucidated. However, they are associated with neutrophils and bacterial
infections(Harrington et al., 2005). Tregs are activated when TGF-β activates STAT5 and
thus, induces transcription of TGF- β and IL-10. Tregs regulate immune responses to
maintain a balance between pro-and anti-inflammatory pathways (Leung et al., 2010). T
follicular helper cells (Tfh) are found in the lymph nodes within the germinal centers and
are important in the development of specific antibody. These cells shuttle antigen
between follicular dendritic cells and developing B cells to help produce specific
antibodies.
B cells
B cells are named for the tissue in which they were discovered- bursa of fabricius.
There, naïve B cells undergo somatic hypermutation to develop low-specificity b cell
receptor (BCR). B cell receptors (BCR) are antibody structures expressed on the surface
of B cells which are “Y” shaped proteins made up of a heavy and a light chain. The C
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terminus of each chain is known as the “constant” domain and helps maintain the
structure of the antibody. The N terminus of each chain goes through hypermutation to
develop specificity to antigens and is known as the variable domain. During
hypermutation, the heavy chain has three genetic regions (V, D, and J) that go through
recombination to produce the strongest affinity for antigen. The light chain only has V and
J regions. The heavy chain also goes through class switching to generate the different
antibody isotypes- Ig (M, D, G, A, and E). Based on the signal provided by T cells via B
cell CD40 and the microenvironment, antibody will switch its heavy chain constant region
to change its effector function (Stavnezer and Schrader, 2014). During development, IgM
and IgD are the first antibodies present on the surface of the B cell. IgM and IgD
antibodies bind poorly but act as first response antibodies. IgG is the most abundant
antibody found throughout the body and is highly specific to its target. IgA is found in
mucosal surfaces and is important during infection that affects mucosal sites such as
nasal passages, lungs, and stomach lining. IgE is associated with type 2 hypermutation,
or an allergic response including mast cell degranulation via binding of FcεR on the cell
surface (Schroeder and Cavacini, 2010).
B cells can mature into short-lived antibody producing plasma cells after
encountering an antigen that binds poorly to its BCR. However, naïve B cells can mature
in the germinal center of a lymph node where it interacts with T follicular helper cells and
follicular dendritic cells to produce highly specific antibody. Follicular dendritic cells
remain in the light zone of a germinal center and act as depots for antigen. There, Tfh’s
collect antigen and act as a secondary presenter of antigen to maturing B cells. When a
B cell has a BCR that binds the antigen, it retreats to the dark zone of GC and goes
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through further somatic hypermutation and isotype switching to produce highly specific
antibody (McHeyzer-Williams and McHeyzer-Williams, 2005).
Adaptive immune response to Hc
In Hc challenge infection studies, resistant sheep show a remarkable ability to
avoid reinfection due to development of effective adaptive immune responses during
primary infection that primes the immune system for future infections (Courtney et al.,
1985; Gamble and Zajac, 1992; Shakya et al., 2011; Bowdridge et al., 2015; Hernández
et al., 2016). Anti-CD4 monoclonal antibodies were used to experimentally deplete CD4 +
cell populations in resistant sheep to determine their importance. After a challenge
infection, these sheep without CD4+ cells had significantly higher fecal egg counts,
decreased numbers of abomasal mucosal mast cells, and reduced eosinophilia. When
compared to control infected randomly-bred sheep, there was no difference, illustrating
the importance of CD4+ cells in an effective immune response against Hc infection. (Gill
et al., 1993).
Helminth infections, including Hc infection, classically lead to a Th2 response
including increased Th2 cells, M2 macrophages, IgA, IgE, and eosinophilia (Courtney et
al., 1985; Gamble and Zajac, 1992; Gill et al., 2000; Bowdridge et al., 2015; MacKinnon
et al., 2015; Estrada-Reyes et al., 2019). Multiple studies have shown IL-4 mRNA in
abomasal tissues as early as 3 days in resistant breeds but not in susceptible breeds
(Robinson et al., 2011b; Jacobs et al., 2016). IL-13, another important Th2 cytokine has
recently been shown to bind and paralyze Hc larvae in vitro, expanding the role of Th2
cytokines in response to Hc infection (Shepherd et al., 2020).
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In vitro culture of L3 with St. Croix PBMC results in reduced motility of the larvae
resulting from direct binding and potential damage to L3 by one or multiple cell types in
the PBMC mixture (Holt et al., 2015). Further experiments showed that PBMC increase
morbidity in addition to reducing motility. In these experiments, ATP was used to measure
morbidity of L3 caused by PBMC, using heat-killed larvae as a control. Third stage larvae
cultured with St. Croix PBMC plus autologous serum led to significantly increased
morbidity compared to L3 cultured with Suffolk derived PBMC and serum. However, L3
cultured with PBMC alone from either breed led to larval death but not at the same level
as heat-killed controls. These data indicate that although PBMC from Suffolk and St. Croix
can affect larval morbidity, St. Croix humoral response enhances the killing (Shepherd et
al., 2017)
Antibody development associated with Th2 response has been implicated in an
effective immune response in resistant breeds. IgG1 and IgA concentrations increase in
serum during Hc infection and are positively correlated with resistance (Gill et al., 1993).
Several other studies have also found increased levels of IgG and IgA, along with IgE in
resistant breeds compared to levels in susceptible breeds, indicating a role in effective
immune responses (Lacroux et al., 2006; Terefe et al., 2007; Bowdridge et al., 2013;
Hernández et al., 2016) In vitro culture of larvae with serum leads to clumping of larvae,
which may play a role in expelling larvae and preventing establishment during infection
(Garza et al., 2017). Th2 cytokines including IL-4, IL-5, CD40L bind their receptors on the
surface of B cells, , providing signals to B cells to induce class switching both to IgA and
IgE, both of which are markers of anti-parasitic immune responses (Purkerson and
Isakson, 1992; Morawetz, 1996; Cerutti, 2008). IgE binds the FcεR1 of eosinophils, mast
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cells, and basophils leading to degranulation and potentially damaging incoming larvae
or established adults. IgE can also bind its receptor on smooth muscle cells and epithelial
cells leading to their contractility also bind to goblet cells leading to mucus secretions, all
leading to the classic “weep and sweep” response to try and clear the parasite out of the
gut. The “weep and sweep” mechanism is also enhanced by IL-4 and IL-13 binding and
STAT6 activation of epithelial and smooth muscle cells (Anthony et al., 2007).
In most adaptive immune responses, antibody acts directly on a pathogen through
binding and neutralizing functions or can target pathogens for destruction by other cells.
The adaptive immune response including antibody and effector memory cells is the main
target of vaccine development. Vaccines introduce a non-infective pathogen or pathogen
molecule to the adaptive immune system without disease so that when that pathogen
infects the body, it is easily recognized and eliminated.
Vaccine Immunology
Vaccines are made up two main components; antigen and adjuvant. Antigens are
added in different forms including: live, attenuated pathogen, native antigen, toxoids
derived from the pathogen, and recombinant protein or polysaccharide. Adjuvants are
used to recruit cells to the site of vaccination to initiate an innate immune response. At
the site of vaccination, dendritic cells mature after interacting with antigen and migrate to
secondary lymph nodes where they present antigen to naive T and B cells, eliciting an
adaptive immune response. The focus in vaccine development is to produce long-lasting,
specific, and protective antibody. Early after vaccination, low-affinity antibodies circulate
in the blood. In the germinal center of lymph nodes, T follicular helper cells act as
intermediates, shuttling antigen between follicular dendritic cells and B cells.
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Administering the appropriate amount of antigen in the vaccine is imperative to have a
long lasting and specific antibody response. During B cell maturation into antibody
producing plasma cells, B cells shuttle antigen between the light and dark zone of
germinal centers. This allows B cells in the dark zone to go through affinity maturation
and produce specific antibodies. Another goal of vaccines is the production of memory B
cells for a rapid response to the pathogen. In addition to activating B cells, vaccines aid
in protection through development and activation of memory T cell responses; this
includes both CD8+ and CD4+ memory T cell populations (Plotkin and Orenstein, 2008).
Other factors considered during vaccine development are types of antigen. Whole
cell vaccines including attenuated live and killed pathogens include multiple antigens,
presenting multiple opportunities to induce protective immunity. However, pathogens are
not always viable options as they can be expensive and difficult to grow (Jasmer et al.,
n.d.) or too dangerous to grow, thus, it is reasonable to utilize synthetically produced
antigens to induce generation of protective humoral immunity.
Adjuvants
Adjuvants are mixed with the antigen or whole cell to enhance a specific immune
response. Based on the adjuvants’ chemical properties, different immune responses can
be induced and contribute to protection against the targeted pathogen. Toll-like-receptors
targets, such as CpG, have been utilized in adjuvant mixes to elicit a specific type of
immune response (Di Pasquale et al., 2015).
Aluminum salt (alum) adjuvants have been used in vaccines longer than any other
adjuvant and are proven to induce antibody responses (Marrack et al., 2009). There are
three mechanisms proposed for alum. The first mechanism of immunogenicity is initiating
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a strong innate immune response through an influx of dendritic cells, neutrophils,
eosinophils, NK cells, and monocytes; these cells produce Th2 polarizing cytokines in
response to alum. These cytokines direct CD11b+ cells to differentiate into dendritic cells
and “M2” phenotype macrophages (Seubert et al., 2008; Tritto et al., 2009; Calabro et al.,
2011a). Dendritic cells then move antigen to draining lymph nodes where adaptive
response can develop. Alum binds and slowly releases antigen, allowing follicular cells to
sample antigen and develop a more specific antibody response (Shi et al., 2001).
However, this “depot” mechanism is hypothesized to depend on site of injection and local
cellular environment (Munks et al., 2010; Hutchison et al., 2012). The final proposed
mechanism of alum is injection induces uric acid and cellular DNA release, both of which
are danger signals leading to a Th2 response (Kool et al., 2008; Marichal et al., 2011).
Quil-A adjuvant is the A-Fraction of saponin from Quillaja saponaria Molina, a
South American tree. Saponins are made up of an aglycone unit bound to carbohydrate
chains. These chemicals also possess detergent properties and are produced by plants,
lower marine animals, and some bacteria (Savage, 2003). Saponin adjuvants have been
used in other sheep vaccine studies and other anti-parasite vaccine trials, including
Taenia ovis, Taenia solium, and Echinococcus granulosus to attempt to induce a
balanced response of Th1, Th2 and Treg (Lightowlers et al., 1996). Quil-A induces CD8+
lymphocyte proliferation, antibody specific humoral response, macrophage-oriented
cytotoxicity, and cytokine production leading to a skewed Th1 response (Newman et al.,
1992; Kensil, 1996; Behboudi et al., 1999; Yui et al., 2001). In a study looking at the effect
of different adjuvants in an experimental infection of Fasciola hepatica, Quil-A induced B
cell proliferation and antibody production, but also a Th1 response. These effects resulted
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in a reduced fluke infection in the lambs (Haçarız et al., 2009). Like many other popular
adjuvants, the mechanism is not completely understood, but it is hypothesized that QuilA causes tissue damage leading to danger signals and deposition of the antigen with the
response leads to a specific cytotoxic cellular response (Cibulski et al., 2018).
Other common adjuvants include water-in-oil (W/O) or oil-in-water (O/W)
adjuvants, or emulsions. Some of the most common emulsion adjuvants are Freund’s
(complete or incomplete) Adjuvant, Montanide, and MF59. These types of adjuvants work
by emulsifying the antigen into tiny droplets of either water or oil which then slowly release
antigen. The emulsion itself also helps enhances appropriate vaccine response for the
targeted pathogen. Incomplete Freund’s adjuvant (IFA) is a W/O emulsion; when heatkilled Mycobacterium tuberculosis is included in the adjuvant, it becomes Complete
Freund’s adjuvant (CFA). CFA induces a Th1 response through activation of
Macrophage-inducible C-type lectin (Mincle). Mincle activation leads to neutrophil
infiltration, antigen-specific T cell responses, antibody production, and inflammatory
chemokine, and cytokine production (Ishikawa et al., 2009; Werninghaus et al., 2009;
Desel et al., 2013). CFA has such harsh local inflammatory side effects that it is not used
in human vaccines. When it is used in vaccines, it is usually used for the initial vaccination
and the subsequent boosters use IFA. IFA induces a Th2 response and slowly deposits
the antigen, leading to stimulation and production of antibody-producing plasma cells
Montanide was developed by Seppic, in France, to enhance immune responses to
recombinant antigens. While alum is good at inducing an antibody response, it is not good
at eliciting a cellular response which is imperative when using recombinant antigens.
Compared to Freund’s adjuvant and alum, Montanide ISA 708, 721, and 70 was found to
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induce consistent adjuvant responses measured by antigen-specific antibody when used
in a peptide vaccine administered to mice (Jones et al., 1990). Since this study, Seppic
has developed several different Montanide ISA adjuvants to induce appropriate antibody
and cellular responses when using synthetic peptides in vaccines in different species;
these include Montanide ISA 720, Monanitde ISA 51, and Montanide ISA 61 VG
(Aucouturier et al., 2002; Khorasani et al., 2016)
MF59 is a squalene-based emulsion adjuvant used in Influenza vaccines in over
20 countries (O’Hagan et al., 2012). It has been shown to increase antigenicity of
influenza vaccines and increase seroconversion rates, which is important for vaccine
efficacy (Nicholson et al., 2001; O’Hagan, 2007; Pellegrini et al., 2009). There is also
evidence of MF59 acting to enhance chemokine recruitment (CCL2, CCL3, CCL4, and
CXCL8) to the site of vaccination leading to increased numbers of CD11b+ cell recruitment
(Seubert et al., 2008). According to studies, the first cells to infiltrate the area are
neutrophils followed by monocytes, eosinophils, and lastly dendritic cells. Recruitment of
these cells increased interaction with antigen and transport of the antigen to the local
draining lymph node for processing. Alum has been found to act similarly but with lower
neutrophil recruitment and less efficient shuttling of antigen to the local draining LN
(Calabro et al., 2011b).
Hc vaccines
There have been many efforts to produce vaccines against Hc. Urquhart et
al.,1966 gave two doses of irradiated larvae 28 days apart followed by a challenge
infection 30 days later to measure protection. This immunization provided no protection
to sheep (Urquhart et al., 1966). Other targets for vaccine candidates include
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excretory/secretory proteins (E/S), native proteins, and recombinant proteins and
peptides. Two adult worm E/S proteins (15 kDa and 24kDa) have been isolated and used
in early vaccine trials. The biological function of these proteins remains unknown but are
most likely associated with modulating the host immune response (Gadahi et al., 2016b).
In the first trial, these proteins were emulsified in dimethyl dioctadecyl ammonium bromide
(DDA) did not elicit protective antibodies (Vervelde et al., 2001). However, the same
research group used whole E/S glycoprotein product and Alhydrogel as the adjuvant for
their vaccine, leading to an 89% reduction in cumulative egg output (Vervelde et al.,
2003). One issue affecting the viability of vaccine candidates is whether the antigens are
recombinant or native. The group of proteins that has shown most efficacy has been
native proteins, specifically hidden gut proteins H11 and H-gal-GP. These proteins are
found in the gut wall of adult H. contortus. Therefore, the immune system would not
normally have access to these proteins. After vaccination, antibody is produced to bind
these proteins to block their function. When a blood meal is taken in, the conjugate
antibody binds these proteins leading to disruption of blood digestion in the worm. This
leads to starvation of the adult, reduced fecundity and expulsion of the worm from the
host gut. These antigens are used in a commercial vaccine, Barbervax®, but is only
available in Australia and New Zealand. Although this vaccine is effective, there are
number of limitations such as maintaining infections in lambs to produce the native
antigens of the vaccine, as well at the number of boosters needed for continued protection
(Emery et al., 2016; Magalhães de Matos et al., 2017). These issues illustrate a need for
improved understanding of the immune response to H. contortus. With a better
understanding of which proteins are important for survival to the parasite as well as which
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proteins are targeted by the immune response, an improved vaccine could be studied
and produced.
Tropomyosin
Tropomyosin (TPM) is a highly conserved protein found in all eukaryotic cells. The
function of this protein varies based on its isoform, but its main role is actin stabilization
and regulation of actin/myosin interactions. Tropomyosin is normally found as a dimerized
α-helical coiled-coil bound along actin. During muscle contraction and release, TPM
regulates the Ca2+-mediated interactions between actin and myosin. It has also been
found in non-muscle cells where it still interacts with actin, but plays a role in cell
migration, cytokinesis and morphogenesis (Gunning et al., 2015).
Although tropomyosin is a conserved protein found in eukaryotic cells, invertebrate
tropomyosins have been identified as main allergens in organisms such as shrimp,
cockroaches, and dust mites (Witteman et al., 1994; Crespo et al., 1995; Rao et al., 1998;
Ayuso et al., 2002). Parasite tropomyosins have also been studied as potential vaccine
candidates in both ectopic and internal parasites (O’Donnell et al., 1989; Folkard et al.,
1996; Taylor et al., 1996; Hartmann et al., 1997; Cao and Liu, 1998; Jenkins et al., 1998;
Nisbet et al., 2006; Nabian et al., 2013; Wright et al., 2016) . Taylor et al., 1996 found
that BALB/c mice vaccinated with a 136 amino acid residue (MOv-14) from the C terminus
of Onchocerca volvulus tropomyosin led to 48-62% reduction in Onchocerca lienalis
microfilaria after infection compared with the control group. Anti-MOv-14 antibodies
levels increased in these mice and recognized Acanthocheilonema viteae product. In a
follow up study, Jenkins et al., 1998 found high levels of anti-MOv-14 antibodies in mice
vaccinated with MOv-14 and had serum-transferable protection. This study also used
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immunogold labeled anti-MOv-14 antibodies on different life stages of O. volvulus to
identify the location of the antigen. Images were developed with TEM and showed
tropomyosin throughout the different life stages’ muscle, skin and cuticle. These results
led the hypothesis that humoral exposure to TPM muscle isoform of dead and dying
parasites may be leading to cross-reactions to cuticle TPM which further leads to
protection from the parasite (Jenkins et al., 1998).
Currently, there is only one vaccine available to prevent H. contortus infectionBarbervax. However, this vaccine requires multiple boosters every season resulting in
increased labor time and cost. Barbervax is only available for commercial use in Australia,
New Zealand, and South Africa. Therefore, other countries including the United States of
America still rely heavily on anthelmintics, resulting in anthelmintic resistance. Developing
an efficacious vaccine against H. contortus requiring fewer boosters than Barbervax
would reduce labor requirements, stress on the animals, and would further reduce the
use of anthelmintics in the sheep industry.
When developing vaccines, understanding both innate and adaptive immune
responses to the targeted pathogen is imperative. H. contortus-resistant sheep serve as
models for developing an effective immune response. As we continue to investigate
effective immune responses against H. contortus, vaccine candidates will continue to
improve.
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Chapter 2: Differential recognition of Haemonchus contortus protein by serum
from parasite-resistant and -susceptible sheep
Abstract
In this study, serum from parasite-susceptible and -resistant sheep was used to
investigate differences in third stage larval (HcL3) antigen binding. Serum was blotted
against Hc whole larvae homogenate (HcLA), L3 protective sheath (cuticle) and
exsheathed L3 (XL3). These immunoblots revealed St. Croix IgG bound a 35 kDa protein
present in cuticle, HcLA, and XL3 antigens. Binding to this protein was not observed using
Suffolk (SUF) serum. NanoLC-MS/MS identified this protein as H. contortus tropomyosincontaining domain. Analysis of HcLA, XL3 and cuticle-specific circulating IgG, determined
by ELISA, revealed higher levels of antigen-specific IgG in Suffolk serum when compared
to St. Croix (STC) serum. “Predicted” peptides within Hc-tropomyosin were selected using
University of Nebraska online epitope predictor and from a study that used peptides to
induce peripheral blood mononuclear cells (PBMC) proliferation in allergic patient cells.
These peptides were synthesized for use in peptide-specific assays. Previously infected
St. Croix had higher titres of peptide-specific IgG in circulation than Suffolk, but the
differences were not significant. Epitope mapping was performed externally using
overlapping tropomyosin peptides to determine which were bound best by St. Croix IgG.
This experiment led to the selection of 4 “mapped” peptides -1, 2, 3, and 4. These results
suggest that St. Croix develop specific antibody to more Hc antigens, which may
contribute to their resistance. These results further led to the selection of four peptides
for use in a vaccine trial against Hc.
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Introduction
Investigations into sheep breed responses to Hc have determined that St. Croix
and other breeds are able to avoid early establishment through different immune
mechanisms (Courtney et al., 1985; Gamble and Zajac, 1992; Burke et al., 2003). By day
7 after infection, there are differences in larval establishment of Hc in St. Croix when
compared to composite wool crosses (Bowdridge et al., 2015). This indicates that there
is an immune response occurring earlier than day 7 in the St. Croix to prevent
establishment; this supports the idea that St. Croix are able to recognize cuticular
components of Hc L3. Early responses in STC to Hc include il4 expression as early as 3
days while SUF do not respond even up to day 7 in abomasal mucosa (Jacobs et al.,
2016).
Serum from primed sheep binds Hc life stages at varying levels. Garza et al. in
2017measured antibody binding by counting the number of larvae swimming freely and
dividing that be the number of larvae initially cultured in the well. The results showed a
higher level of antibody binding to L3 when compared to XL3 or L4, suggesting an antigen
recognized on the outer surface, or cuticle, of L3. Early antibody and complement binding
to L3 may contribute to early larval expulsion (Garza et al., 2017).
While the exact protein makeup of the Hc cuticle has not been determined,
researchers have determined there are both 2ME-soluble and -insoluble fractions of
protein. The 2ME-soluble fraction was digested in collagenase, indicating collagen-like
protein makeup. This study also determined a 1:0.8 ratio of hydroxyproline: proline, which
may play a role in oxygen transportation from the blood across the cuticle (Fetterer, 1989).
However, studies have yet to identify antigenic proteins in the cuticle, which may be
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playing a role in antibody binding and a role in immunity to L3 H. contortus (Garza et al.,
2017).
One major setback in discovering vaccine targets for gastrointestinal nematodes
is their multi-stage life cycles within the host. While Hc has a simple life cycle, it goes
through 3 different life stages inside the host, making identification of target antigens that
will induce a protective response to difficult. In the 1989 study by Fetterer et al.,
characterization of proteins in the cuticle from second molt, L3, and adult, revealed that
each life stage has different surface proteins. This result contributes to difficulty in
identifying a potential vaccine target.

To date, the most successful Hc vaccine

candidates, proteins H11 and H-gal-GP, have been found in the gut of adult Hc (LeJambre
et al., 2008). Antibody binding “hidden” antigens requires a blood meal by fourth stage
(L4) or adult H. contortus. Once inside the parasite the antibody in the blood can bind its
target, disrupting blood metabolism. Rather than waiting for the larvae to molt and
become hematophagous (L4) leading to damage in the abomasum, if an external L3
antigen is identified and targeted, the larvae would not develop any further, causing
negative effects produced by L4 and adult life stage feeding. A vaccine target inducing
high levels of antibody targeting the L3 cuticle may be optimal. Another advantage of
identifying peptides associated with the cuticle is the ability to synthesize the peptides in
vitro. Hidden gut antigens are extracted directly from adults, which means sheep have to
be constantly infected and sacrificed for production of these antigens.
The aim of these experiments was to determine differences in specific Hc protein
binding by antibody from Suffolk and St. Croix. After performing immunoblots with Suffolk
and St. Croix serum binding different components of H. contortus antigens including
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whole third stage larval homogenate (HcLA), exsheathed L3 homogenate (XL3), and
cuticle alone, tropomyosin was identified in all three samples as bound by St. Croix IgG
but not by Suffolk IgG. These data indicate that St. Croix produce antibody specifically to
proteins from H. contortus while Suffolk do not. Further, after minimal differences between
St. Croix and Suffolk binding of “predicted” peptides, a more specific epitope mapping
experiment using St. Croix antibody to bind overlapping tropomyosin peptides led to the
selection of 4 peptides for use in a vaccine trial. These observations may help develop
differences in St. Croix ability to clear H. contortus infection earlier than observed in
Suffolk sheep.
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Materials and methods
Animals and housing
All sheep utilized in these studies were born at the West Virginia University Animal
Husbandry Farm (Morgantown, WV, USA) and maintained on a raised and expanded
metal floor in order to prevent unintended Hc infection. All animal protocols were
approved by the West Virginia University Animal Care and Use Committee (ACUC-130308.1).
Haemonchus contortus culture and collection
Three SUF wethers were infected with 10,000 H. contortus L3 and served as the
source for all larvae used in this study. Packed cell volumes (PCV) and fecal egg counts
(FEC) were monitored weekly. Feces were collected and mixed with autoclaved peat
moss and activated carbon, then incubated at 30o C for 7 days. Larvae were isolated
using the Modified Baermann’s apparatus (Baermann, 1917) then washed and stored in
sterile PBS at 4o C until use.
Ovine infection
Five STC and SUF sheep were born and raised at the West Virginia University
Animal Husbandry farm (Morgantown, WV, USA) and were kept on a raised, expanded
metal floor to allow feces to fall through. These animals were infected orally with 10,000
third stage H. contortus larvae (L3) and infection was allowed to persist for 6 weeks.
Infected animals were treated with levamisole (Agrilabs, St. Joseph, MO, USA) (8 mg/kg)
and then were allowed to rest for 3 weeks. The animals were then given another dose of
10,000 L3 H. contortus, orally and the infection continued for another 6 weeks. The
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animals were then treated with another dose of levamisole in order to eliminate infection.
Weekly FEC and PCV were collected to determine infection status. Animals were not
infected when serum samples were collected for immunoblot and ELISA assays.
Serum collection
Blood was collected into 10-ml untreated vacutainer tubes (Tyco, Cork, Republic
of Ireland) via jugular venipuncture and centrifuged at 750 x g for 20 minutes at 4o C.
Serum was removed and pooled by treatment group. The serum was aliquoted and frozen
at -20o C until use.
H. contortus L3 protein isolation (HcLA)
Approximately 200,000 third stage H. contortus larvae were collected into a 15 ml
conical tube and centrifuged into a small pellet. Larvae in 2ml PBS (Corning, NY, USA)
were transferred to a glass tube homogenizer on ice and were ground until homogenized.
The sample was aliquoted into microcentrifuge tubes and centrifuged at 10,000 x g for 20
minutes. Supernatant was collected and protein concentration were quantified using 660
nm protein assay (Pierce Biotechnology, Rockford, IL, USA).
H. contortus L3 cuticle protein isolation
This method is modified from (Boisvenue et al., 1991). Two hundred and twenty
thousand total L3 were used to collect protein for cuticle protein per isolation. Twenty
thousand L3 were pelleted and resuspended in 2 ml PBS were pipetted into each sealedtop T25 flask (11 flasks). Twenty-three ml of Earle’s Balanced Salt Solution (GE
Healthcare Bio-Sciences, Pittsburgh, PA, USA), and 250 µl Penicillin-streptomyosinneomyosin antibiotic (Sigma Aldrich, St. Louis, MO, USA) were added to reach total
volume of 25 ml. Then, CO2 was “bubbled in” using flexible tubing for 30 seconds. The
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top was quickly sealed and the flasks were placed on a shaker overnight at 37o C. Cuticles
were collected by pouring flask content over a modified Baermann apparatus. The liquid
containing the cuticles was collected from fluid above the filter, then re-filtered two more
times. The cuticle solution was collected and centrifuged at 5000 x g for 7 minutes.
Volume was reduced to 4.5 mL of PBS and cuticle solution was further separated into 3
microcentrifuge tubes. Cuticles were pelleted by centrifugation and supernatant was
taken off to 300 µl of PBS, yielding approximately 50,000 cuticles per tube. 1.2 ml of ST
Buffer (0.125 M Tris-HCl, 1% SDS, 5% β-mercaptoethanol) was added to each tube and
heated at 98.4o C for 2 minutes. Contents were transferred to a BeadBug homogenizer
tube filled with 0.5mm triple pure zirconium beads (Benchmark Scientific, Edison, NJ,
USA) and contents were homogenized 7 times for two minutes with 2 minutes of icing in
between homogenizations (Benchmark Scientific, Edison, NJ, USA). Samples were
centrifuged at 10,000 x g for 20 minutes at 4o C and supernatants were collected and
combined. Protein samples were then concentrated using TCA protein precipitation. The
pellet was resuspended in ST Buffer and quantified using 660 nm Assay with Ionic
Detergent Compatibility Reagent added (Pierce Biotechnology, Rockford, IL, USA).
H. contortus exsheathed L3 (XL3) protein isolation
One-hundred thousand L3 were suspended in 5 ml of PBS in a T25 flask and mixed
with bleach and deionized water for a 15% bleach solution. Larvae were mixed on a
shaker for 5 minutes followed by 15 minutes in 37o C incubator. Exsheathed larvae were
then washed twice in deionized water and suspended in 5 ml of water. Larvae were then
combined with 25 mL of Earle’s Balanced Salt Solution (GE Healthcare Bio-Sciences,
Pittsburgh, PA, USA) and 250 µl of Pen/strep/neo (Sigma Aldrich, St. Louis, MO, USA)
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and incubated at 37o C with 5% CO2 overnight. Exsheathed larvae were collected and
washed two times in PBS and homogenized using BeadBug Homogenizer as mentioned
in 2.5.2. Protein was quantified using 660 nm Protein assay (Pierce Biotechnology,
Rockford, IL, USA).
Immunoblots
Laemmli Buffer 2X (Bio-Rad, Hercules, CA, USA) + 5% β-mercaptoethanol was
added at a 1:1 volumetric ratio to each sample (2.32 µg of each protein) and incubated at
95o C for 5 minutes. Each protein (1.16 µg) at a volume of 15 µl was added to respective
well in a 4-15% MiniProtean TGX 10 well gel (Bio-Rad, Hercules, CA, USA). 10 µl of Dual
Xtra Standards (Bio-Rad, Hercules, CA, USA) was used. SDS-PAGE was performed and
proteins were transferred to PVDF membrane using iBlot 2 Dry Blotting System
(ThermoFisher Scientific, Waltham, MA, USA). Following transfer, the membrane was
blocked overnight at 4o C in Tris-Buffered Saline + 3.5% BSA. Primed STC and SUF
serum were diluted 1:50 in TBS + 3.5% BSA + 1% Tween-20, added to its respective
membrane, and incubated at room temperature for 1 hour on a shaker. The membranes
were washed four times for 5 minutes in tris-buffered saline +0.01% Tween-20.
Secondary antibody, IRDye 680RD Donkey Anti-Goat IgG (Li-Cor, Lincoln, NE, USA) was
diluted 1:15,000 in TBS + 3.5% BSA + 1% tween-20 and was added to respective
membranes and incubated at room temperature for 1 hour. Membranes were washed
four times with TBS-Tween-20 (0.1%) followed by a single PBS wash for five minutes. All
membranes were imaged with Li-Cor Odyssey Imager at their respective wavelengths
(Li-Cor, Lincoln, NE, USA).
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Antigen-Specific ELISAs
Total ovine immunoglobulin ELISA was performed following protocol provided by
the manufacturer (Sheep Total Immunoglobulin ELISA Kit, MyBioSource, San Diego, CA,
USA). Cuticle, XL3, and HcLA antigens were diluted in 0.05M Carbonate/Bicarbonate
buffer pH 9.4 a concentrations of 5 µg/ml, 3 µg/ml, and 4 µg/ml, respectively, in 100 µl
per well of a 96 well 4 HBX plate (ThermoFisher Scientific, Waltham, MA, USA), and
incubated overnight at 4oC. Wells were washed five times with PBS-T and blocked PBS
+ BSA (0.1%) for 1 hour at RT. STC or SUF serum was added and incubated at RT for
one hour at 1:6400, 1:3200, or 1:1600 dilutions in PBS-B to wells coated with cuticle, XL3,
and HcLA antigens, respectively. Wells were washed five times with PBS-T. Mouse antisheep IgG:HRP conjugated antibody (Sigma-Aldrich, St. Louis, MO, USA) was diluted in
PBS-B at 1:6400, 1:800, or 1:3200 for cuticle, XL3, HcLA respectively and 100µl of each
was incubated in its respective well for one hour at RT. Wells were washed ten times with
PBS-T. TMB was added and reactions developed for 15 minutes followed by addition of
50uL of 2M H2SO4. Absorbance was read at 450nm using Epoch BioTek Plate Reader
(BioTek, Winooski, VT, USA). Wells following the same protocol but with no serum were
used as blank wells.
Peptide-Specific ELISAs
Nebraska peptide was synthesized based on an online antigenic prediction
software

based

out

of

University

of

Nebraska

(http://sysbio.unl.edu/SVMTriP/prediction.php). Peptides 54, 66, 80, and 81 were
selected from a list of shrimp epitopes shown to induce proliferation of CD4 + T cells in a
study by Ravkov et al., (2013), and the amino acid sequences matched H. contortus
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amino acid sequences. “Predicted” peptides were synthesized by GenScript (Piscataway
Township, NJ, USA) and peptide sequences are reported in Table 1. “Mapped” peptides
selected from epitope mapping results were produced by BioMatik. These sequences can
be found in Table 2.2. Peptides were diluted in 0.05M Carbonate/bicarbonate buffer pH
9.4 and plated at 5 µg/ml in a volume of 100 µl/well in a 96 well 4 HBX plate (ThermoFisher
Scientific, Waltham, MA, USA). The plate was incubated overnight at 4o C; the next day,
the plates were set on the bench top to acclimate to room temperature followed by 5
washes with PBS-T. Wells were blocked with 200 µl of 3% Powdered Skim Milk (Kroger,
Cincinnati, OH, USA) in PBS-T for one hour at room temperature on a shaker. The wells
were washed five times with PBS-T and coated with appropriate serum samples diluted
1:80 for predicted peptides and 1:50 for mapped peptides in 3% Skim Milk PBS-T and
serial diluted 1:1 down the plate, leaving the last row blank. The plate was incubated for
two hours at RT on a shaker. After five more washes with PBS-T, wells were coated with
100 µl mouse anti-sheep IgG:HRP conjugated antibody (Sigma-Aldrich, St. Louis, MO,
USA ) diluted 1:2000 in 3% Skim milk in PBS-T for one hour at room temperature RT on
a shaker. Wells were washed ten times with PBS-T and developed with 100 µl of TMB
(ThermoFisher Scientific, Waltham, MA, USA) for 12 minutes and stopped with 100 µl of
2M H2SO4. Absorbance was read at 450nm using Epoch BioTek Plate Reader (BioTek,
Winooski, VT, USA).
Tropomyosin Western Blot
Laemmli Buffer 2X (Bio-Rad, Hercules, CA, USA) + 5% β-mercaptoethanol was
added at a 1:1 volumetric ratio to each sample (2.32 µg of each protein) and incubated at
95o C for 5 minutes. 1.16 µg of each protein (at a volume of 15 µl) was added to its
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respective well in a 4-15% MiniProtean TGX 10 well gel (Bio-Rad, Hercules, CA, USA).
10 µl of Dual Xtra Standards (Bio-Rad, Hercules, CA, USA) was used. SDS-PAGE was
performed and proteins were transferred to PVDF membrane using iBlot 2 Dry Blotting
System (Thermo Fisher Scientific, Waltham, MA, USA). Following transfer, the membrane
was blocked overnight at 4o C in Tris-Buffered Saline + 3% BSA (TBS-B). Primary
antibody LS-C502037-50 Rabbit Polyclonal IgG anti-Charybdis feriata Tropomyosin
(LSBio, Seattle, WA, USA) diluted 1:800 in TBS-B + 0.1% Tween20 and incubated at
room temperature for one hour. The membrane was washed four times for five minutes
in 3 ml of TBS+ Tween20 (0.1%). The Secondary antibody was added Ab6802 Donkey
Anti-Rabbit IgG (HRP) (Abcam, Cambridge, United Kingdom) at a dilution of 1:1000 in
TBS-B + 0.1% Tween20 and incubated at room temperature for one hour. The membrane
was washed four times for five minutes in 4 ml of TBS + Tween20 (0.1%) followed by one
final wash in PBS. 1-Step TMB-Blotting (Thermo Scientific, Waltham, MA, USA) was
added to the membrane until the bands developed; the membrane was washed with water
to stop the development.
Mass Spectrometry
Proteins were separated via 1D SDS-PAGE as mentioned previously and stained
with Coomassie blue. The corresponding 35 kDa band bound by IgG was excised and
sent to the University of Nebraska, Lincoln for Mass Spectrometry analysis and
identification. The gel band was washed 3 times with ammonium bicarbonate/acetonitrile
to remove the stain and SDS, prior to shrinking of the clear gel pieces with 100%
acetonitrile followed by air drying. Trypsin was then added and digestion was carried out
overnight at 37oC overnight. The digests were then dried down and dissolved in 16 µL of
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2.5% acetonitrile and 0.1% formic acid. 5 µL of the digest was processed by nanoLCMS/MS using a 1h gradient on a 0.075mmx250mm C18 Waters CSH column feeding into
a QExactive HF mass spectrometer. All MS/MS samples were analyzed using Mascot
(Matrix Science, London, UK; version 2.5.1). Mascot was set up to search the
cRAP_20150130 database and Uniprot (selected for Haemonchus contortus, 20170515,
21874 entries) assuming the digestion enzyme trypsin. Mascot was searched with a
fragment ion mass tolerance of 0.060 Da and a parent ion tolerance of 10.0 PPM.
Deamidation of asparagine and glutamine, oxidation of methionine and carbamidomethyl
of cysteine were specified in Mascot as variable modifications. Scaffold (version
Scaffold_4.7.5, Proteome Software Inc., Portland, OR) was used to validate MS/MS
based peptide and protein identifications. Peptide identifications were accepted if they
could be established at greater than 80.0% probability by the Peptide Prophet algorithm
(Keller, A et al Anal. Chem. 2002;74(20):5383-92) with Scaffold delta-mass correction.
Protein identifications were accepted if they could be established at greater than 99.0%
probability and contained at least 2 identified peptides. Protein probabilities were
assigned by the Protein Prophet algorithm (Nesvizhskii, Al et al Anal. Chem.
2003;75(17):4646-58). Proteins that contained similar peptides and could not be
differentiated based on MS/MS analysis alone were grouped to satisfy the principles of
parsimony. Proteins sharing significant peptide evidence were grouped into clusters.
PBMC isolation
Whole blood was collected into 10-mL EDTA-treated vacutainer tubes (Tyco, Mansfield,
MA, USA) via jugular venipuncture. Blood samples were centrifuged at 1,000 x g for 20 minutes
at room temperature (RT). Buffy coats containing white blood cells were transferred to sterile 15
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mL conical tubes and resuspended in 1 mL of sterile phosphate buffered saline (PBS). Red blood
cells (RBC) were lysed with ACK lysis buffer (Lonza, Walkersville, MD). The remaining cell pellet
in buffer was layered over sterile lymphocyte separation media (SPG 1.077 g / mL; Corning,
Manassas, VA) and centrifuged at 400 x g for 20 minutes at RT. The middle layer containing
PBMC was collected and washed two times in sterile PBS. PBMCs were collected and mixed 1:1
with trypan blue and counted using Bio-Rad TC-20 automated cell counter (Hercules, CA). The
cells were then resuspended in complete media containing RPMI-1640 with 2mM L-gluatmine
(GE Healthcare Life Sciences, Logan, UT), 10% fetal bovine serum (FBS) (Corning, Corning, NY)
and penicillin-streptomycin antibiotic (Sigma Aldrich, St. Louis MO, USA).

Proliferation Assays
PBMC from naïve and infected sheep were plated in complete media at 50,000 cells/well
in 96-well cell culture plates. Cells were incubated at 37o C with 5% CO2 with peptides at 20ug/mL,
ConA was added at 10 ug/ml, LPS was added at 50 ug/ml, and negative control cells were
incubated without antigen in complete media. The plates were incubated 37o C with 5% CO2 for
72 hours. CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega, Madison, WI,
USA) was added to each well for 1.5 hours before being read at 490nm using Epoch BioTek Plate
Reader (BioTek, Winooski, VT, USA). Treated cell proliferation signals were corrected to the
untreated control cells. Within naïve groups or infected groups, proliferation levels were compared
between St. Croix and Suffolk. Within breed groups, infected groups were compared to naïve
groups

Epitope mapping for vaccine peptides
LC Sciences produced the peptide chip and ran the epitope mapping service used in this
experiment. The chip included 1158 unique 12 to 15 mer tiling peptides from the sequence of H.
contortus tropomyosin with 3 to 4 redundancies. All peptide sequences were acetyl capped at N
terminal. Multiple quality control probes were included on each chip. Blocking buffer (BB1) used
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was SuperBlock TBS (ThermoFisher, Waltham, MA, USA) with 0.05% Tween-20 and 0.05%
Triton X-100, pH 7.0. Binding buffer (BB2) used was 1X PBS, pH 7.0. Washing buffer (WB) used
was BB2 with 0.05% Tween-20 and 0.05% Triton X-100, pH 7.0. To block, BB1 was added to the
chip and incubated at 4o C overnight. The chip was washed with 1 mL of TBS washing buffer. The
chip was scanned at PMT700 in Cy5 channel. The chip was washed with 1mL of BB2 at 25o C for
1 hour. 10X diluted St. Croix sheep serum was added to the chip in BB2 and incubated at 25o C
for 2 hours. The chip was washed with BB2 at 25o C for 39 minutes followed by an incubation with
50 ng/mL donkey anti-sheep IgG Cy5 conjugate (Sigma Cat. # AP184S) in BB2 at 25o C for 1
hour. The chip was washed with 0.5 mL WB at 25o C for 30 minutes and finally the chip was
scanned for an image of binding at PMT 700 in Cy5 channel.

Statistical Analysis
Data in figures 2.1 and 2.2 were analyzed via one-way ANOVA performed with the
Holm-Sidak Method for mean comparisons using SigmaPlot Software (Systat Software,
San Jose, CA, USA). Peptide ELISA data were analyzed using one-way ANOVA using
Geisser-Greenhouse correction in GraphPad Prism 8. Figure 2.7 data were analyzed via
two-tailed unpaired t-test in GraphPad Prism 8. Proliferation assay data were analyzed using
two-way ANOVA with Tukey multiple comparisons testing in GraphPad Prism 8 (GraphPad
Software, CA, USA) . Significance was determined when P ≤ 0.05.
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Results
IgG Immunoblot of H. contortus L3 antigens and Total ovine immunoglobulin
ELISA
STC IgG bound many L3 proteins between the sizes of 35 kDa and 250 kDa (Fig.
2.1a). Of particular interest was the antigen with an apparent weight of 35 kDa bound by
STC IgG, but not by SUF IgG, in all three H. contortus homogenates including in the
cuticle. Therefore, we decided to investigate the identity of this protein. In order to confirm
that increased antigen binding by STC IgG was due to IgG specificity and not due to
higher concentrations of antibody in STC serum used in the immunoblot, we performed a
total ovine immunoglobulin ELISA on both STC and SUF serum (Fig. 2.1b). SUF serum
contained a significantly higher concentration of total immunoglobulin in circulation when
compared to STC serum, again confirming that the results of the immunoblot were not
due to higher levels of immunoglobulin in STC serum (19.417 mg/ml vs.15.832 mg/ml,
respectively); (P < 0.05).
Antigen-specific ELISAs
Antigen-specific ELISA were performed using cuticle, HcLA, and XL3 antigens to
determine IgG binding by STC and SUF antibody (Fig. 2.2). All three ELISAs resulted in
higher levels of absorbance by SUF IgG when compared to STC IgG L3-specific IgG
1.249 vs 1.038 (P=0.002), XL3-specific IgG 1.893 vs.1.189 (P<0.001), cuticle-specific IgG
0.204 vs. 0.114 (P= 0.001). These data combined with the immunoblot indicate that
although SUF antibody bind whole homogenates at higher absorbances, the antibody
may not be as specific as seen by STC antibody.
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35 kDa antigen identification and confirmation
H. contortus L3 protein was separated using 1D electrophoresis along a 4-15%
gradient TGX polyacrylamide gel and was stained with Coomassie blue. The band at 35
kDa, matching the band bound by St. Croix serum, was extracted and sent to the
University of Nebraska, Lincoln to be identified via mass spectrometry. The protein band
was destained and digested using porcine trypsin and identified using LC-MS/MS. Mascot
was used to analyze the results using cRAP_20150130 database and Uniprot databases
(selected for Haemonchus contortus, 20170515, 21874 entries); (Fig. 2.3). The antigen
identified by Mass Spec was H. contortus tropomyosin-domain containing protein
U6PH16_HAECO. To confirm that tropomyosin was the identity of the 35 kDa protein, a
western blot was performed using HcLA and probed with anti-Charybdis feriata
tropomyosin antibody. The results showed a band at both 35 kDa and 40 kDa (Fig 2.4).
Predicted and mapped peptide-specific ELISAs
The first set of peptides in Table 2.1 were selected based on epitope prediction
software or from a publication that studied proliferation of PBMCs from patients allergic
to shrimp tropomyosin. ELISAs were performed to detect antibody specific to these
individual peptides with serum from naïve and primed STC and SUF. The serum samples
in first row of the ELISA plate were diluted 1:50 and were serially diluted by half down the
plate. Area under the curve analysis was performed to determine if there are antibody
differences between primed or naïve St. Croix and Suffolk. Based on the results, there
were no differences between groups- breed or infection status.
After the initial ELISAs showed no difference between groups to predicted
peptides, new peptides were selected via epitope mapping. As mentioned in materials
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and methods, PSTC antibody was used in epitope mapping to screen for antigenic
peptides of tropomyosin. These peptides were produced and screened with the same set
of serums as “predicted” peptides. Figure 2.6 shows area under the curve analysis of the
ELISA data. Again, there were no significant differences in antibody specific to peptides
between breed or infection statuses. Average area under the curve was calculated for the
PSTC group for both predicted and mapped peptides. There was no significant difference
Proliferation assay of peptides
In figure 2.8, PBMC were isolated from infected STC or SUF, or naïve STC or SUF.
Infected animals had active infections and had been infected for 5 weeks. PBMC were
incubated in triplicate with no antigen, 10µg/ml ConA, 50 µg/ml LPS, or 20µg/ml peptide
at 37o C for 72 hours. These cells were then assessed to determine whether their cells
were able to respond to the peptides without vaccination. Figure 2.8a shows the percent
that stimulated

PBMC proliferated more than PBMC with no antigen. PSTC cells

proliferated significantly more than NSUF when cultures with all tested antigens and ConA
except for when mixed with peptide 81. PSTC proliferated more than PSUF when
incubated with ConA (P < 0.05), LPS (P < 0.01), and Nebraska peptide (P < 0.01). Lastly,
PSTC proliferated more than the NSTC pool of cells only when incubated with Nebraska
peptide (P < 0.0001) or peptide 80 (P < 0.05). Figure 2.8b used PBMC from the same
pool of cells but were cultured with the mapped peptides. PSTC cells proliferated
significantly more than NSUF (P < 0.01) when cultured with all tested antigens, LPS, and
ConA except for when mixed with peptide 1 (P =0.0512) and 4. PSTC proliferated more
than PSUF and NSTC when incubated with LPS (P < 0.001, P < 0.05, respectively), and
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peptide 2 (P < 0.001, P < 0.05, respectively) and 3 (P < 0.0001, P < 0.01, respectively).
PBMC incubated with peptide 81, 1, and 4 did not significantly proliferate.
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Discussion
Results from this study provide evidence of St. Croix IgG, but not Suffolk IgG,
recognition of a 35 kDa protein found in H. contortus larval homogenates. This protein
was identified via nanoLC-MS/MS as H. contortus tropomyosin domain containing
protein. After observing the differences in antibody binding, ELISAs were performed to
confirm that the immunoblot results were not due to overall higher levels of circulating
antibody in St. Croix serum. Interestingly, total immunoglobulin and antigen-specific IgG
levels were significantly lower in St. Croix; serum used for these experiments was
collected from animals that had two artificial infections but had been cleared of infection
with Levamisole. Therefore, the antibody levels reflect that of circulating, resting levels.
Garza et al., (2017) performed an in vitro study in which St. Croix or Suffolk sheep
serum was cultured with third (L3), exsheathed third (XL3), or fourth stage (L4) larvae.
These experiments revealed L3 clumping around antibody and complement complexes,
reducing larval ability to move independently. In theory, this mechanism would prevent
larval escape of the “weep and sweep” mechanisms of IL-13 and IL-4, known to be
produced in response to helminth infection. However, this clumping effect was not as
prominent when tested with XL3 or L4’s, indicating that there may be an antigen
recognized on the surface of the L3 cuticle that was increasing this clumping. These data
led to the investigation of antigens bound by sheep antibody using immunoblot techniques
(sheep serum as primary antibody and anti-sheep IgG as the secondary antibody) and
antigens from homogenized cuticle, larvae and exsheathed larvae. The 35 kDa protein
bound strongly by St. Croix IgG was identified as tropomyosin domain containing protein
and was found in all three protein samples. Suffolk IgG bound different larval antigens
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from the homogenates, however none were as prominent as St. Croix IgG binding
tropomyosin domain containing protein.
To confirm that the blot results were not due to higher levels of antibody in St. Croix
serum, antigen-specific IgG and whole ovine immunoglobulin ELISAs were performed,
with serum from both breeds taken while the sheep were cleared of infection. The data
show that Suffolk had higher resting levels of circulating total immunoglobulins and
antigen-specific IgG. Circulating IgG levels were higher in both naïve and infected Suffolkcrossed compared to St. Croix (Jacobs, 2013). Our western blot data indicate that
although levels of circulating IgG were higher in Suffolk serum, St. Croix IgG was better
able to bind proteins found in L3, XL3 and cuticle homogenates. Zajac et al. studied
antigen-specific IgG levels in St. Croix compared to susceptible Dorset sheep. Contrary
to our experiment, Zajac et al. found that St. Croix had higher levels of serum IgG specific
to larval antigen, L3 exsheathing fluid, and 2nd molt cuticle proteins (Gamble and Zajac,
1992). However, the differences in Zajac’s study and this one included the age of the
sheep when serum was collected as well as the breeds used in the experiment. Zajac’s
study used 9 week post-challenged 23 week- old lambs while our study used year old
sheep that had been cleared of infection. Domestic breeds such as Suffolk sheep acquire
protection to H. contortus as they age and are exposed more often; this mechanism is not
sufficient in younger lambs leading to higher incidences in death (Courtney et al., 1985).
Studies of the early cellular response to H. contortus have shown that by day 3
after a challenge infection, there are significantly higher numbers of neutrophils as well
as expression of IL-13 and IL-4 in the abomasum in St. Croix when compared to
susceptible wool breeds (Bowdridge et al., 2015; MacKinnon et al., 2015; Jacobs et al.,
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2016). These studies illustrate the presence and implicate a need for a cellular response
to clear infection early. The exact mechanism of cellular response and resistance is still
being explored. Microarray analysis was used to find that 27 days after H. contortus
infection, St. Croix sheep with Barbados blackbelly ancestry had greater expression of Fc
γ receptor in abomasal lymph node tissue than the wool sheep used in this experiment;
fecal egg counts in the St. Croix sheep were 2.5x lower than those found in the wool
breed, although this difference was not statistically significant (MacKinnon et al., 2009).
Although there are many isotypes of FcγR, FcγRIII expression in mice has been found to
augment Th2 responses depending on the antigen specificity of IgG1 (Bandukwala et al.,
2007). Although we did not test the expression of sheep Fc γ receptor, based on these
previous studies, the higher antigen specificity found in St. Croix serum tested in this
experiment may could be associated with a higher expression of Fc γ receptor and
potentially contributing to an enhanced Th2 response needed to expel H. contortus to
prevent establishment of L3’s.
Currently, Barbervax is the only vaccine available against Haemonchus contortus,
however it is only available in in Australia and Canada. This vaccine is made up of native
antigens and saponin adjuvant to induce antibody production against hidden gut antigens
H-gal-GP and H11. Protection from infection requires five or six administrations during
the highest risk season for infection; administration of this vaccine is also required in
subsequent

years

but

at

lower

doses

(Reese

et

al.,

1999)

(http://www.wormboss.com.au/tests-tools/management-tools/the-barbervax-vaccineprogram.php). A vaccine comprised of the outer membrane protein of the infective stage
may reduce number of treatments needed to maintain protection, as the animals would
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constantly encounter the antigen during grazing. Developing a vaccine using recombinant
peptides would also reduce the use of infected animals for antigen collection.
The H. contortus protein bound highly by St. Croix IgG was identified as
tropomyosin domain containing protein. Tropomyosin is a known antigen and the main
allergen of other parasites and shellfish and is highly conserved among invertebrates. It
has many different isoforms and is made up of two alpha helical subunits that twist around
each other in a coiled-coil homodimer (Reese et al., 1999; Sereda et al., 2010) and plays
a role in thin filament activation. In Figure 2.4, the two bands recognized by antitropomyosin antibody may be explained multiple isotypes of tropomyosin. One lab found
an isoform of tropomyosin in Onchocerca volvulus infective and microfilarial life stage
cuticles, supporting our findings of tropomyosin in L3 cuticle protein homogenate.
Although the function of tropomyosin in the cuticle may be unknown, some have
postulated that exposure to muscle tropomyosin from dead or dying microfilariae was
leading to a humoral response that allowed for cross-reactivity with the cuticle
tropomyosin(Jenkins et al., 1998). This may also be the case for H. contortus infections.
In the current experiments, St. Croix IgG binding to tropomyosin in all three L3
homogenate samples warrants further studies regarding the location of tropomyosin on
the cuticle as well as its presence in larval muscle.
Tropomyosin has been identified as a vaccine candidate for multiple helminth
species such Trichostrongylus colubriformis, Onchocerca volvulus, Onchocerca lienalis,
Acanthocheilonema viteae, and Schistosoma japonicum with varying levels of reductions
in worm burden ((O’Donnell et al., 1989; Folkard et al., 1996; Taylor et al., 1996; Cao and
Liu, 1998; Harrison and Bianco, 2000; Hartmann et al., 2006) Tropomyosin has also been
62

identified as vaccine candidates for the poultry red mite, Dermanyssus gallinae with
mortality of the mite at 19% (Wright et al., 2016) and larval stages of the cattle tick,
Boophilus annulatus (Nabian et al., 2013). The C terminus of tropomyosin is also known
to be well-conserved and therefore may act with cross-reactivity and protection against
other invertebrate parasites. These studies indicate that invertebrate tropomyosin has
been well-documented as vaccine candidates and should be investigated further to
determine its efficacy in protecting against H. contortus infection in susceptible sheep.
The next set of experiments were focused on determining antigenic epitopes from
tropomyosin. Initially, the first goal was to produce H. contortus tropomyosin in vitro
through cloning. However, the initial PCR performed to amplify the gene for insertion into
a vector was unfruitful. After one successful round of amplification of the correct size
gene, it was inserted in a PGEM-T Easy vector and further amplified. However, when
sequenced, the resulting gene was identified as 18S ribosomal RNA of Pelodera
cylindrica (a free-living nematode). These results led to investigations into tropomyosin
epitopes that had been used in previous experiments.
The first peptide (Nebraska) selected for synthesis was predicted using online
epitope prediction software from the University of Nebraska. The other 4 peptides (54,
66, 80, and 81) tested were selected from a list of shrimp tropomyosin peptides that
experimentally caused proliferation of PBMC from patients with shrimp allergies (Wang
et al., 2012; Ravkov et al., 2013). From this list, the sequences were blasted against H.
contortus tropomyosin-domain containing protein and 4 were selected based on
sequence homology. Peptide-specific ELISAs were performed. The primary antibody was
serially diluted serum and the secondary antibody was anti-sheep IgG. The data showed
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that St. Croix had slightly higher resting levels of peptide-specific IgG when compared to
Suffolk IgG for peptides Neb, 66, 80, and 81. Although not significant, STC had slightly
higher titres of IgG specific to peptides Neb, 66, and 80. These results support the
immunoblot results showing higher STC peptide-specific IgG than SUF.
The second group of “mapped” peptides were selected after the first set showed
low IgG specificity. Epitope mapping technology is used to identify specific peptides from
a protein that are bound by serum of a selected group. In this case, primed St. Croix
serum was used in the epitope mapping experiment. 12-15 overlapping amino acid
sequences of tropomyosin were printed on a glass slide. Next St. Croix serum coated the
plate with the peptides followed by secondary fluorescently labeled antibody for detection.
Results were sorted based on signal emitted by the fluorescent label. Four peptides were
synthesized based on these results- peptides 1, 2, 3, and 4. ELISAs were performed with
the same serum samples using the new peptides. Again, there was no significant
difference between any of the groups. While IgG is the most abundant antibody produced,
IgA and IgE are both associated with helminth infections and resistance and therefore
antigen-specific IgA and IgE experiments may lead to more putative vaccine candidates
as well.
Proliferation assays are used to narrowly measure the cellular immune response
to a pathogen. In this experiment, the proliferation assay was performed to determine if
cells from sheep that had been infected with H. contortus were able to respond to antigens
if cultured directly. PBMCs are made up of lymphocytes, dendritic cells and monocytes.
If a cellular response has been developed in vivo to a pathogen then these isolated cells
should be able to respond and proliferate in response in vitro. Infected and naïve St. Croix
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and Suffolk PBMCs were isolated and cultured with each peptide at 20µg/ml. Cell cultures
were incubated for 72 hours and proliferation was measured. PSTC cells proliferated
significantly more than PSUF when cultured with peptides Nebraska, 80, 2, and 3. PSTC
cells proliferated more than NSUF in response to Nebraska, 54, 66, 81, 2, and 3. Levels
of proliferation were also greater in PSTC compared to NSTC after culture with Nebraska,
and 3. In the first experiments of this chapter, serum from the “primed” animals was
collected after the animals had received a primary and secondary infection. However,
infected animals used in this experiment were actively infected, which may have affected
the results. Their immune systems may not have been developed and therefore sensitivity
to antigens and thus a propensity to proliferate may have been affected.
These results illustrate that infected St. Croix have better cellular recognition and
response than naïve St. Croix or any infection status of Suffolk to tropomyosin peptides
tested. Without a cytokine profile from the supernatant of the cells, these results can only
show that there was a cellular response leading to proliferation. Some studies have
shown that there is no difference in PBMC proliferation between St. Croix and other
susceptible breeds (Gamble and Zajac, 1992) supporting our results, while other resistant
breeds (Canaria Hair Breed) have been shown to have accelerated cell proliferation after
infection (Guo et al., 2016).
What started as an immunoblot to determine differences in breed-specific protein
binding led to the selection of 4 peptides for testing in a vaccine trial against H. contortus.
These peptides have been conjugated to KLH to enhance their immunogenicity and will
be mixed with adjuvant for vaccination. Overall, this research has revealed a distinct
breed difference in antibody specificity to different components of H. controtus L3.
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Tables and Figures
a.

Primed St. Croix Serum

Primed Suffolk Serum

b.

Figure 2.1. Immunoblot of H. contortus proteins with St. Croix or Suffolk serum
and total circulating total immunoglobin
(a) SDS-PAGE using 4-15% MiniProtean TGX gels were used to separate the proteins;
lane 1: Dual Xtra Protein ladder lane 2: PBS- negative control; lanes 3, 4, 5 contained1.16
µg of XL3, HcLA, Cuticle protein separated respectively. Primed STC and primed SUF
serum were used as the primary antibodies and anti-sheep IgG was used as the
secondary antibody. Immunoblots of Hc antigens recognized by STC IgG and SUF IgG.
Arrow indicating 35 kDa band recognized by STC IgG but not SUF IgG. (b) Total
circulating immunoglobulin levels in serum from STC and SUF at resting levels after
challenge infection were measured using total ovine immunoglobulin ELISA kit
(MyBioSource). (*P < 0.05).
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Figure 2.2. Circulating levels of HcLA, XL3 -specific IgG.
SUF had significantly higher levels of circulating HcLA -specific IgG (P=0.001)
XL3(P<0.01), and cuticle-specific IgG (P=0.002) when compared to STC resting levels of
antigen-specific IgG. Antibody levels were measured at 450 nm. (** P < 0.01)
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a.

b.

Figure 2.3. Mass spectrometry analysis of 35 kDa protein bound by St. Croix
antibody.
35 kDa protein identified as H. contortus tropomyosin domain containing protein. SDSPAGE was performed to separate HcLA. The 35 kDa band was excised and sent to the
University of Nebraska, Lincoln for mass spec analysis. After trypsin digestion of the 35
kDa band, nanoLC-MS/MS was performed to identify the peptide. (a) Mass spectra
peptide peaks and (b) peptide coverage compared to known H. contortus tropomyosin
domain containing protein analysis of peptides detected during nanoLC-MS/MS.
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4- HcLA (XL3)

3- HcLA (L3)

2- PBS (negative
control)

1- Protein Ladder

Figure 2.4. Western blot confirming tropomyosin presence in H. contortus larval
antigen at the same size as the immunoblot.
Western blot was used to confirm tropomyosin in HcLA sample. SDS-PAGE was
performed to separate protein samples. The protein was transferred to a PVDF
membrane and blotted with rabbit anti-Charybdis feriata tropomyosin. The secondary
antibody used anti-rabbit IgG-peroxidase labeled. The membrane was developed with
one-step TMB (Thermo Scientific).
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Table 2.1. Predicted antigenic tropomyosin peptides based off of epitope
predictor and previous tropomyosin research
Peptide
Name
Nebraska
Peptide (Neb)
54
66
80
81

Amino Acid Sequence
AERSVQKLQKEVDRLEDELV
RYKDEVARKLAMVEA
ELRVVGNNLKSLEVS
RAEFAERSVQKLQKE
FEARSVQKLQKEVDR

Reference
University of Nebraska
http://sysbio.unl.edu/SVMTriP/prediction.php
Ravkov et al. (2013)
Ravkov et al. (2013)
Ravkov et al. (2013)
Ravkov et al. (2013)
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Figure 2.5. Comparisons of breed differences and infection status of predicted
tropomyosin peptide-specific IgG
Area under the curve analysis was performed on antibody titres starting at a 1:80
dilution and serially diluted down the plate 1:1 to determine differences based on breed
and infection status. (Nebraska: P= 0.3889, 54: P=0.1674, 66: P= 0.4110, 80: P=
0.0527, 81: P= 0.3878).
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Table 2.2. Mapped antigenic tropomyosin peptides bound by St. Croix antibody in
epitope mapping experiment
Peptide
Name
1
2
3
4

Amino Acid Sequence
LERAEERAEAGENKIVELC
VDESERVRKVMENRSFQDC
ADEVQRQLEEERKKREDAEC
EADRKYDEVARKLAMVC
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Peptide-specific IgG
Peptide-specific
1.0

PSTC

IgG

PSUF

1.6

NSTC

AUC

Area under the curve

1.4
1.2

NSUF
0.5

1
0.8
0.6

0.0
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0.4
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66
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81

Peptide

0.2
0
1

2

3

4

Peptide

Figure 2.6 Comparisons of breed differences and infection status of mapped
tropomyosin peptide-specific IgG
Area under the curve analysis was performed on antibody titres starting at 1:50 serialdiluted 1:1 starting at a to determine differences based on breed and infection status.
(Peptide 1: P= 0.2501, Peptide 2: P= 0.0732, Peptide 3: P= 0.0900, Peptide 4: P=
0.3250).

Figure 2.7 Primed St. Croix IgG area under the curve of predicted vs mapped
peptides
Average area under the curve was determined for the STC IgG of grouped predicted vs
mapped peptides to help select which group to use in vaccine (P = 0.0646).
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Figure 2.8. Proliferation of PBMC after 72-hour incubation with 20 µg/ml ConA,
5 µg/ml LPS, and 20 µg/ml peptides reported as percent above untreated cell
proliferation.
PBMC were isolated from infected or naïve STC and SUF and were cultured with T cell
mitogen ConA (10 µg/ml), B cell mitogen LPS (50 µg/ml), and each of the potential
vaccine peptides (20 µg/ml). Proliferation results were corrected to antigen-free PBMC
wells before statistical analysis. *: P <0.05, **: P <0.01, ***: P <0.001, ****: P <0.0001.
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Chapter 3. Efficacy of vaccination with mapped peptides conjugated to KLH in
susceptible sheep
Abstract
An effective vaccine for use against H. contortus would mean reduced used of
anthelmintic and improved animal health. Development of an effective vaccine using
synthetic peptides would improve the rate of vaccine production, as the current vaccine
requires live larvae. Four peptides based on the epitope mapping assay (1, 2, 3, and 4)
were conjugated to carrier protein KLH. KLH was used to enhance the antigenicity of the
peptides. Montanide ISA 61 VG was the adjuvant used in this vaccine to promote an
appropriate immune response. SUF sheep were used in this vaccine trial, as they are a
known susceptible breed. Four groups of N=6 sheep each were used in this experimentvaccinated, adjuvant only, infection only, and naïve (uninfected). Vaccinated and adjuvant
only groups were immunized and boosted with adjuvant + peptides, or adjuvant only.
Other than to naïve, all groups received a primary infection of 10,000 Hc L3. Six weeks
after primary infection, animals were dewormed with Levamisole and given a two-week
rest period followed by a secondary infection with 10,000 Hc L3. Weekly fecal and blood
samples were collected to monitor infection and to monitor antibody production specific
to vaccine peptides. In the vaccinated group, antibodies specific to vaccine peptides were
detectible one week after vaccination and remained high throughout the experiment; the
other groups had no detectible antibody to the peptides (p < 0.01). However, there was
no significant difference in infection outcome between the infected groups during primary
or secondary infections- FEC, PCV or adult worm count. qPCR results showed that the
infection only group had higher gene expression levels of foxp3 (p < 0.05), while both the
vaccinated and adjuvant only groups had higher levels of il17a (p < 0.05), indicating a
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potential effect of the adjuvant. This vaccine trial revealed that SUF can respond to a
peptide vaccine in this peptide +adjuvant construct despite the lack of protection provided.
Gene expression revealed elevated levels of IL-17A which may have affected the overall
vaccine efficacy. Future vaccine formulations should include a different adjuvant to
promote a stronger Th2 response to ultimately reduce fecal egg count.
Introduction
Vaccines are used to elicit an adaptive immune response that are meant to protect
an organism from future infections or reduce the severity of a pathogen. In most vaccines,
there are two components- the adjuvant and the antigen. Adjuvants are substances used
to elicit a specific type of immune response. Developing a vaccine in sheep has produced
some difficulties, including which adjuvant is best. This is especially true in the case of
developing a vaccine against H. contortus. Although there are multiple studies that have
used different adjuvants, there is not a clear best choice. Adjuvants used in previous
studies include alum (Alhydrogel), saponin (QuilA), Diethylaminoethyl dextran (DEAE),
Freund’s Complete Adjuvant, and Fruend’s Incomplete Adjuvant (Vervelde et al., 2003;
Piedrafita et al., 2013; Fawzi et al., 2015; Gadahi et al., 2016a; Kandil et al., 2017;
González-Sánchez et al., 2018). Therefore, in this experiment a different, newer adjutant
was used- Montanide ISA 61 VG. Montanide ISA vaccines are water in oil emulsions
designed to slowly release antigen for a long-lived antibody response as well as a cellular
response. The goal of this adjuvant in context of our vaccine was to induce a long-lasting
antibody response and contribute cells to an appropriate cellular response.
Antigens are imperative to vaccines, as they are the target of the specific immune
response built during vaccination. If the antigen is located in a region of the pathogen that
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is not accessible by the immune response, it would not be an appropriate selection for
vaccination. In the case of commonly tested Hc antigens, the most successful vaccine
antigens have been “hidden” gut antigens that are involved in blood metabolism.
Antibodies are produced to recognize these antigens, bind the proteins when a blood
meal is taken by L4s and adults, and the worms cannot process their meals- starving the
worms (Fawzi et al., 2015; Magalhães de Matos et al., 2017; González-Sánchez et al.,
2018). Antigen production is also important in terms of vaccine development, recombinant
proteins do not always fold properly and therefore have to be screened for antigenicity,
native proteins and whole cell require production of the pathogen in large volumes, and
peptides are not always antigenic enough and have to be bound to carrier proteins. For
this vaccine, we selected peptides after unsuccessful production of recombinant protein.
The specific peptides were selected based off epitope mapping results.
Previous vaccine trials for Hc focus largely on adult antigens. This means that for
the vaccine to work, larval stages have to establish and develop. Therefore, this study
focused on targeting L3 and L3 cuticle proteins to prevent establishment of H. contortus
in the abomasum. There are advantages of both preventing L3 establishment and killing
adult worms after establishment. In the case of targeting L3, the goal would be to prevent
any pathogenesis from occurring caused by L4 and adults feeding. An added benefit of
preventing adult establishment would be to prevent egg production and shedding into the
environment.
Vaccinations against H. contortus do not have to be 100% effective to be helpful
to producers. If a one-time vaccine achieves partial protection, then other management
practices can be utilized for preventing and treating infection. In this study, 24 SUF lambs
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were separated into 4 groups- vaccinated with antigen and adjuvant, adjuvant only
control, infection only control and naïve.
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Materials and Methods
Animals and housing
All sheep utilized in these studies were born at the West Virginia University Animal
Husbandry Farm (Morgantown, WV, USA) and raised on clean concrete floors order to
prevent parasite infection. All animal protocols were approved by the West Virginia
University Animal Care and Use Committee (IACUC-191002974.1).
Haemonchus contortus culture and collection
Three SUF were infected with 10,000 H. contortus L3 and served as the source
for all larvae used in this study. Packed cell volumes (PCV) and fecal egg counts (FEC)
were monitored weekly. The feces of these animals were collected using cloth apparatus
secured over the sheep’s rear end. These feces were collected, broken up, mixed with
autoclaved peat moss and activated carbon, and allowed to incubate at 37 o C for 7 days.
Larvae were collected via modified Baermann’s apparatus, washed in PBS and stored in
sterile PBS at 4o C until use.
Generation of Hc infective larvae and experimental infection procedure
Twenty-four SUF sheep were born and raised at the West Virginia University
Animal Husbandry farm (Morgantown, WV, USA) and were raised parasite-free on a
concrete floor. 18 of these animals were infected orally with 10,000 third stage H.
contortus larvae (L3) while 6 remained naïve. Infection levels were monitored via fecal
egg counts and packed cell volume. This infection continued for 7 weeks. Infected
animals were treated with levamisole (Agrilabs, St. Joseph, MO, USA) (8 mg/kg) and
rested for 2 weeks. The same animals were infected with another 10,000 L3 H. contortus
and the infection continued until sacrificing the animals 5 weeks later. Animals were
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euthanized with Euthasol (Virbac, Carros, France) administered by the attending
veterinarian.
Ovine sample collection
Samples of abomasal lymph node, and the three sections of abomasal tissue were
collected after euthanasia and were stored in RNAlater. Abomasums were washed
contents were collected and mixed up to 2 L with water. 200 mL of abomasal sample was
mixed with 200 mL of formalin for final adult worm counts. Contents were sifted through
and adult worms were counted.
Serum collection
Blood was collected into 10-ml untreated vacutainer tubes (Tyco, Cork, Republic
of Ireland) via jugular venipuncture and centrifuged at 750 x g for 20 minutes at 4o C.
Serum was pipetted off the top of the blood clot and pooled by treatment group. The
serum was aliquoted and frozen at -20o C until use.
Packed Cell Volume
Blood was collected into 5-ml EDTA vacutainer tubes (Tyco, Cork, Republic of
Ireland) via jugular venipuncture. Blood from these tubes were collected into StatSpin™
Glass Microhematocrit Tubes (HemoCue, Angelholm, Sweden), packed with clay, and
centrifuged for 2 minutes using the StatSpin® CritSpin™ Microhematocrit Centrifuge
(HemoCue, Angelholm, Sweden). PCV levels were measured using StatSpin CritSpin
Model S120 Digital Microhematocrit Reader (HemoCue, Angelholm, Sweden).
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Fecal Egg Count
Fecal samples were collected weekly and 2g from each sample was mixed with 28
mL modified McMaster Solution. Solids were separated from the solution using cheese
cloth and the solution was saved for counting eggs. The solution with the eggs were
pipetted onto McMaster Slides (Chalex Corporation, Issaquah, WA, USA) and eggs in all
chambers were counted. To calculate eggs/gram the raw egg counts were multiplied by
50.
Composition of vaccine used in study
Peptides 1-4 were conjugated to KLH and synthesized by BioMatik (Wilmington,
DE, USA). Each antigen-KLH was reconstituted by dissolving in 0.5 ml 0.22µm filtered
8M Urea. 0.5mL 0.03uM sterile-filtered water was added to bring the final concentration
of the mixture to 10mg/ml. 62.5 µl of each antigen (for a total of 625 µg/antigen) was
mixed together with 1000 µl of sterile 10X PBS and 2250 µl of 0.03µm sterile-filtered
water. This mixture was layered over 6500 µl adjuvant, SEPPIC Montanide ISA 61 VG
(Paris, France) in IKA DT-20 eco Tube with rotor-stator element (IKA, Staufen, Germany).
The tube with contents was placed into the Ultra -Turrax ®Tube Drive Basic (IKA, Staufen,
Germany), mixed at 1100 rpm “speed 3” for 1 minute followed by mixing at 4000 rpm
“speed 9” for 3 minutes. The same process was repeated for the adjuvant only group, but
the antigen volumes were replaced with 0.03µm sterile-filtered water. The mixtures were
kept in their mixing tubes overnight at 4o C transferred to endotoxin-free vaccine vials for
vaccination.

85

Table 3. 1. Peptides used in vaccine and their amino acid sequences
Peptide
1
2
3
4

Amino acid sequence (N to C terminus)
LERAEERAEAGENKIVELC w/or w/out (KLH)
VDESERVRKVMENRSFQDC w/or w/out (KLH)
ADEVQRQLEEERKKREDAEC w/or w/out (KLH)
EADRKYDEVARKLAMVC w/or w/out (KLH)

Administration of Vaccine, Adjuvant Control, and Boosters
Six SUF sheep were used per group. Vaccines and adjuvant controls were
administered via intramuscular injection into neck muscle. The site of vaccination was
sheared and wiped with isopropanol for 10 seconds before injection. The vaccine and
adjuvant control were mixed before use and 1mL of vaccine (250 µg total antigen)
/adjuvant control was injected using a 20 G needle. The sheep were monitored for signs
of distress and discomfort intermittently for 12 hours. The sheep were then checked daily
for the next 5 days. The same process was repeated for giving the booster vaccination
and adjuvant control 4 weeks after initial vaccination.
Peptide-specific ELISAs
Unconjugated vaccine peptides were diluted to 1mg/ml in DI water. 4HBX plates
(ThermoFisher Scientific, Waltham, MA, USA) were coated with 100 µl a mix of all 4
peptides diluted in 0.05M Carbonate/Bicarbonate buffer to a concentration of 2.5 µg/ml
per peptide, and were incubated overnight at 4o C. Wells were washed five times with
PBS-T and blocked for 1 hour at room temperature with PBS-T + 3% Skim Milk (PBS-B)
(Kroger, Cincinnati, OH, USA). Plates were washed five times with PBS-T. Sheep serum
was added at respective dilutions in PBS diluted down the plate by half for a final volume
of 100 µl per well. The plates were incubated at RT for 2 hours and washed with PBS-T
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five times. Mouse anti-sheep IgG:HRP conjugated antibody (Sigma-Aldrich, St. Louis,
MO, USA) was diluted 1:2000 in PBS-B and incubated at RT for 1 hour. Wells were
washed ten times with PBS-T. TMB substrate (ThermoFisher Scientific, Waltham, MA,
USA) was added for 15 minutes and development was stopped using 2M H 2SO4.
Absorbance was read at 450nm using Epoch BioTek Plate Reader (BioTek, Winooski,
VT, USA).
RNA extraction and cDNA synthesis
50-80 mg of LN tissue was sectioned from sample in RNAlater (ThermoFisher
Scientific, Waltham, MA, USA) and placed in a 5 ml polypropylene tube. 1mL RNA Bee
was added and the section was homogenized using a tissue homogenizer. Samples were
kept on ice before and after homogenization. Contents were transferred to 2ml
microcentrifuge tube. 120 µl chloroform:isoamyl alcohol was added and the tube was
shaken vigorously for 15 seconds followed by rest on ice for 5 minutes. After resting, the
samples were placed in a centrifuge and spun at 14000 x g for 15 mins at 4oC. The
aqueous solution was collected (top layer of the tube contents) and were mixed with equal
parts ice-cold isopropanol. Contents were mixed gently and placed at -20o C overnight.
The next day, the tubes were centrifuged at 14000 x g for 15 mins at 4oC. The supernatant
was removed and replaced with 500 µl 75% ethanol for washing. The tubes were spun
again 14000 x g for 10 mins at 4oC and the wash step was repeated. Supernatant was
removed and the RNA pellet was allowed to dry in an exhaust hood. The pellets were
resuspended with 35-50 µl molecular grade water depending on the size of the pellet.
RNA concentrations and 260/280 ratios (above 1.8 is “pure” RNA) were determined using

87

the Take3 addition of the BioTek Synergy H1 microplate reader (BioTek, Winooski, VT,
USA). RNA was stored at -80o C until use.
DNA was prepared using the qScript™ XLT cDNA SuperMix (Quantabio). 4 µl 5X
RT master mix was mixed with 1 µg and incubated in a T100 Thermal Cycler (Bio-Rad,
Hercules, CA, USA). The reaction was completed as 25o C for 5 minutes, 42o C for 60
minutes, 85o C for 5 minutes and infinite at 4o C. cDNA samples were quantified with
Take3 addition of the BioTek Synergy H1 microplate reader (BioTek, Winooski, VT, USA).
cDNA samples were diluted using molecular grade water to 50 ng/µl and stored at 80o C
until use.
Gene expression
Assays were run using CFX96 system (Bio-Rad, Hercules, CA, USA). Taqman
Assay was made up of 1 µl 20X TaqMan Gene expression assay (Applied Biosystems.
Foster City, CA, USA), 2 µl (100 ng) cDNA templates, 10 µl 2X TaqMan Gene Expression
Master Mix (Applied Biosystems. Foster City, CA, USA), and 7 µl RNase-free water for a
total volume of 20 µl per reaction. The reaction was: 95o C for 10 minutes followed by 40
repeated cycles of 95o C for 15 seconds followed by 60o C for 20 seconds. Relative fold
changes were determined using ΔCt values [Ct (test) – Ct (reference)] and derived using
2- ΔΔCt where the reference gene used for normalization was GAPDH.

88

Table 3. 2. Forward and reverse primers used in qRT-PCR

F Primer (5’→ 3’)

R Primer (5’→ 3’)

Accession Number

GAPDH

CAGGAGCACGAGAGGAAGAG

AATGTATGGAGGTCGGGAGA

HM043737

GATA-3

ATGAAACCGAAACCCGATG

GAACACAGACACCACGGAAG

NM_001252183.1

IL-4

GCTGAACATCCTCACATCGAG

TTCTCAGTTGCGTTCTTTGG

M31736.1

T-bet

TACTACCGAAGCCAGGAAGC

AGAGTTCGCATGGAGTGGAA

DQ152994.1

IFNG

ATGACCTGTCGCCAAAATC

GCAGGCAGGAGAACCATTAC

NM_001009803.1

FOXP3

GAAACAGCACATTCCCAGAGT

GGATGAGGGTGGCATAGGT

FJ491732.1

IL-10

TTTCCCTGACTGCCCTCTAA

GCTCCCTGGTTTCTCTTCCT

NM_001009327.1

IL-17A

GGAACACGAACTCCAGAAGG

ACTTGGCCTCCCAGATCA

LN835312.1

GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; IL-4: interleukin-4; T-bet: T-box
expressed in T cells; IFNG: interferon gamma; Foxp3: forkhead box P3; IL-10: interleukin-10; IL17A: interleukin-17A.

Statistical Analysis
Two-way ANOVA with Tukey’s multiple comparisons test were performed in GraphPad
Prism. When groups were compared to each other by weekly values (repeated values)FEC, PCV, antibody titre, Geisser-Greenhouse correction was applied. Significance was
set at p < 0.05.
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Results
Table 3.3 describes the treatment groups in which group 1 is the vaccinated group,
group 2 is the adjuvant only group, group 3 is the infection only group, and group 4 is the
naïve group. Groups 1, 2, and 3, were infected with 10,000 L3 10 weeks post- initial
vaccination, given 7 weeks to stay infected followed by deworming and a secondary
infection of 10,000 L3 that was carried out 5 weeks (Figure 3.1). Packed cell volume and
fecal egg counts were measured weekly to track infection levels. As expected, the naïve
group maintained the highest PCV. All three infected groups followed the same trend of
PCV and after reinfection, maintained the same PCV as the naïve group (Figure 3.2a).
Fecal egg counts were not statistically significant between the infected groups, except for
weeks 15 and 16 post-vaccination in which the adjuvant only group had a significantly
lower FEC than the infection only group (Figure 3.2b). While not significant, the infection
only group had higher FEC than either the vaccine or adjuvant groups. The same trend
was seen in the abomasal adult worm counts. Naïve sheep stayed naïve through the
whole experiment (Figure 3.2c).
A simple measurement of active immune response and recruitment of lymphocytes
to the sire of infection is local lymph node hypertrophy. Lymph nodes from the lesser
curvature of the abomasum were collected and weighed. Average total lymph node
weight per sheep was significantly higher in all infected groups when compared to the
naïve group (Figure 3.3a). The vaccinated sheep has significantly higher counts of lymph
nodes compared to both infected and naïve groups, while the adjuvant only group had
significantly more lymph nodes than the naïve group only (Figure 3.3b). Figure 3c
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illustrates that although the infected group had lower number of lymph nodes, each lymph
node had significantly greater mass than those in any of the other groups.
One of the goals of vaccination is to induce antibodies specific to the antigen used
in vaccines. Figure 3.4 shows the average antibody titre of each group specific to a mix
of all 4 antigens over the course of the experiment. As early as week 1 post vaccination,
there is detectible specific antibody produced by animals that were vaccinated. After
boosting, specific antibody titres reached their peak and leveled off for the remainder of
the experiment. The other groups maintained the same level of antibody specific to
antigens throughout the experiment. The lowest tested titre was reported (serum diluted
1:50- titre of 1.69897), as these groups did not have an increase in antibody levels.
After sacrificing the animals, abomasal lymph node samples were taken and kept
in RNAlater until gene expression was run. GAPDH was run as the house keeping gene
and all gene expression reported is corrected with GAPDH followed by the control
(uninfected) group. Table 3.5 compares gene expression fold change between the
groups. The infection only group had higher levels of Foxp3 compared to either the
vaccinated or adjuvant only group (P< 0.05). IL-17A levels were higher in both the
vaccinated and adjuvant only group compared to the infection group but were not different
from each other (P< 0.05), illustrating an adjuvant effect.
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Discussion
Throughout the world, H. contortus plagues both goat and sheep industries. As of
2020, the only commercially vaccine available is BarberVax and it is only available in New
Zealand, South Africa, Australia, and the UK (by subscription). While this vaccine is
mostly effective, it requires multiple boosters every season rather than inducing long-term
protection. There have been many other anti-Hc vaccine experiments, but success rates
have been highly variable. Based on our previous experiments and experiments
throughout the literature, we developed and performed a vaccine experiment with Suffolk
sheep- a known susceptible breed. Based on the FEC and adult worm count results, there
was no protection induced by the vaccine. However, this vaccine did induce antibody
production in the sheep that lasted throughout the whole experiment after one vaccination
and one early boost.
As mentioned in previous chapters, the antigens selected for this vaccine were
broadly based on STC antibody binding greatly to a protein band that was later identified
via mass spec as Hc tropomyosin. Further, the specific peptides used in the vaccine were
selected after performing an epitope mapping assay of Hc tropomyosin with STC
antibody. Four peptides with the highest average binding value in this assay were
selected for the vaccine and are listed in Table 1. Because peptides are poor antigens
when administered alone in a vaccine, KLH was conjugated to the C-terminus of each
peptide during synthesis. KLH is a large protein isolated from the hemolymph of the
mollusk Megathura crenulate. It is known to be a T-cell dependent antigen, which is
important for priming T and B cells in an early immune response. These responses are
also important for inducing proper antibody production and class switching (House, 2010).
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This vaccine experiment showed that Suffolk were able to produce antibody to the
peptides used in this vaccine. Even with high titres specific to the vaccine antigens in the
vaccine group, there was no difference in infection levels based on FEC and adult worm
count between the vaccine, adjuvant only, and infection only groups.
IgG was the only antibody tested for this experiment. Although there was ample
IgG specific to the peptides, the isotype may have played a role in lack of protection. IgG
is generally a circulating antibody, which means it is found in the blood. For the antibody
to bind its target, it must encounter it and for IgG to come in contact with the parasite,
there would have had to have been blood in the abomasum. Under uninfected
circumstances, there is not blood in the abomasum. However, once the host is infected
and L4 and adults are established, their blood meals lead to release of blood into the
abomasum; this is how BarberVax works. BarberVax induced antibodies against “hidden”
gut antigens. Therefore, when L4 and adults take their blood meals, antibody can bind its
target and inhibits blood metabolism. In the case of the vaccine from our study, the
antibody is targeting tropomyosin which we identified in samples of L3 and XL3
homogenates. Because IgG is in the blood, low levels of L4 and adult Hc may be
important to release blood and prevent further establishment of Hc (Janeway et al., 2001).
To determine why this vaccine did not work, identifying the location of tropomyosin
in all parasitic life stages of Hc will be imperative. If tropomyosin is only found in L3 stage,
then another vaccine trial in which the animals are initially vaccinated and boostered
followed by a low-dose infection (5,000 L3 to allow blood feeding and release of antibody
into the gut) and a final challenge infection of 10,000 L3. While the goal of the vaccine is
to induce protection before the animals encounters the parasite, vaccines must be finely
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tuned to allow the best chance of effectiveness. If animals can be given a low dose
infection and can maintain that controlled level of infection to reduce the chance of being
infected with more of the pathogen, then that may be a factor that has to be tested.
Another component of the vaccine that could have affected its potency is the
adjuvant selection. The adjuvant used in this experiment was Montanide ISA 61 VG, a
water-in-oil adjuvant designed for use in animals. Water-in-oil and oil-in-water adjuvants
are used to induce both cellular and humoral response. ISA 61 VG was selected because
it has been marketed to prolong the antibody response as well as induce a cellular
response. RNA was extracted from samples of abomasal lymph nodes and qPCR was
run on Th1 (tbet, ifng), Th2 (gata3, il4), Treg (foxp3, il10) and Th17 (il17a) genes. There
was no significant difference in the groups between Th1 and Th2 groups, but foxp3 was
significantly upregulated in the infected only group. Il17a was significantly upregulated in
both the vaccinated and adjuvant group compared to the infection only group but was not
different between the two groups. These data indicate that the infection only group may
have a higher population of Treg cells in the lymph node which may be reducing the ability
of Th2 cells to expand.
Shepherd et al, found that both STC and SUF monocytes co-cultured with L3 had
early increased levels of inflammatory markers. However, after 15 hours, STC saw a
decrease in these markers and an increase in Th2 cytokines while SUF Th1 expression
remained high, suggesting STC had switched monocyte phenotype from Th1 towards
Th2 and SUF maintained a Th1 profile(Shepherd, 2019). These results indicate that early
Th1-type response may be important but switching to a Th2 response may be the key in
their ability to clear Hc early. While these experiments were shorter term than the vaccine
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trial, others have also found that Th2 response is important in clearing Hc infections (H.
S. Gill et al., 1993; Gill et al., 2000; Lacroux et al., 2006; Terefe et al., 2007; Bowdridge
et al., 2013; MacKinnon et al., 2015; Jacobs et al., 2016; Middleton et al., 2020)
Future studies using the same antigens for vaccination would benefit from
exploring the use of different adjuvants such as Alum. Alum is known to induce a strong
antibody response (Tritto et al., 2009). In previous Hc vaccine studies the adjuvants QuilA, Alum, Adju-Phos, and Diethylaminoethyl (DEAE)-dextran have been tested for their
efficacies. These studies have all utilized hidden gut antigens so testing them with an
external antigen may result in different protections. In this initial vaccine study, the reason
for using the adjuvant we used was find a balance between humoral and cellular
responses.
In summary, this vaccine trial demonstrated the ability of Suffolk lambs to develop
a specific antibody response to peptides after vaccination. This study also illustrated a
need for selecting different antigens or adjuvants could improve the efficacy of a vaccine
against Hc. Gene expression of abomasal lymph nodes revealed an adjuvant effect. This
effect was an increase in il17a expression. However, the vaccine did not elicit protection
from Hc infection. The sheep industry continues to lose money by disease caused by H.
contortus infection. Therefore, continuing to expand antigen discovery efforts may be
imperative.
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Tables and figures
Table 3. 3. Vaccine trial groups
Group

N=

Adjuvant

Peptide Mixture

Hc (10,000
L3)

1 (Vaccinated)

6

+

+

+, +

2 (Adjuvant Only)

6

+

3 (Infection Only)

6

4 (Naive)

6

+, +
+, +

6 Suffolk sheep were used in each group. Adjuvant + peptide mixture (the vaccine) was
administered to group 1. At the same time, adjuvant was administered to group 2. Groups 1, 2,
and 3 were given two oral challenges of 10,000 L3 H. contortus. Group 4 remained naïve and
without any vaccine treatment.

Figure 3. 1. Vaccination and challenge schedule for vaccine trial.
This schematic shows the schedule of vaccinations by week and by group. Groups 1
and 2 were vaccinated at day 0. 4 weeks later, the same sheep were boostered with the
same vaccines. After 6 weeks, Groups 1, 2, and 3 were give an oral gavage of 10,000
L3 and this infection persisted for 7 weeks. These animals were dewormed and two
weeks later were challenged with 10,000 L3. 5 weeks later, all animals were sacrificed.
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a.

c.
b.

Figure 3. 2. Weekly and final infection parameters.
(a) Weekly packed cell volumes were used to monitor for anemia caused by infection.
Yellow star shapes indicate week of infection; blue triangle indicates week of
deworming. (b) Weekly fecal egg counts were taken and performed in triplicate per
animal (# denotes significance of vaccinated vs naïve, * denotes significance of
adjuvant only vs naïve, + denotes significance of infection only vs naïve, a denotes
difference of adjuvant vs infection only). (c) Adult worm counts in the abomasum were
determined after sacrifice. (*: P < 0.05, **: P < 0.01, ***: P < 0.001, ****: P < 0.0001)
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Figure 3. 3. Abomasal lymph node weight and counts.
After sacrifice, abomasal lymph nodes were removed, counted and weighed. (a)
Vaccinated, adjuvant, and infection groups all had significantly higher total lymph node
mass (per animal) compared to the naïve group (**: P < 0.01, ***: P < 0.001). (b) Lymph
nodes were removed and counted; * denotes significant difference of group vs naïve (p<
0.05), # denotes significant difference of vaccinated vs infection only (P < 0.05). (c) weight
per lymph node was calculated by dividing the lymph node count by total weight; **
denotes significant difference of infection only vs vaccine (P < 0.01), # denotes significant
difference of infection only vs adjuvant only (P < 0.05), +++ denotes significant difference
of infection only vs naive (P < 0.001)
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Vaccine Peptides-Specific IgG Titres
✱✱

log(dilution factor)

6

Vaccinated
Adjuvant Only
Infection Only

4

Naive
2

0
0

10

20

Week Post Vaccination
Figure 3. 4. Vaccine peptides- specific IgG.
ELISA were performed by coating high-binding plates with a mixture of all 4 peptides used in the
vaccine. The primary antibody used was individual sheep serum and the secondary antibody used
was mouse anti-sheep IgG:HRP. The lowest dilution tested was 1:50, explaining the lowest log
(dilution factor) at 1.69. Weeks in which the appropriate groups were vaccinated are marked with
a black bolt and the weeks of challenge infection are marked with a red bolt. Starting at week 2post vaccination and lasting to sacrifice, vaccinated lambs had significantly higher levels of
peptide-specific IgG compared to all groups (P < 0.01).
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Table 3. 4. Gene expression of abomasal lymph node sections.
Vaccinated

Adjuvant only

Infection only

gata3

2.731 ± 1.023

1.989 ± 0.489

1.245 ± 0.344

il4

4.589 ± 1.998

2.425 ± 0.379

3.543 ± 1.241

tbet

4.744 ± 2.097

4.138 ± 1.721

2.612 ± 1.961

ifng

2.268 ± 0.602

3.349 ± 0.572

4.446 ± 1.040

foxp3

4.708 ± 1.249

6.952 ± 1.187

9.230 ± 2.158a

il10

1.668 ± 0.979

1.157 ± 0.087

1.962 ± 1.125

il17a

8.474 ± 2.491 b

9.077 ± 2.831b

2.491 ± 0.437

Abomasal lymph nodes were collected at the time of sacrifice. 50 mg of the largest lymph node
collected from each sheep was used gene expression analysis. Fold change is reported ± SEM.
Fold change (FC) was calculated using Δct relative to housekeeping gene GAPDH and ΔΔct
relative to naïve sheep. Different superscript letters indicate significance difference from those
unlabeled in shared row. P < 0.05
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Chapter 5: Discussion
Background
The major goal of this research was to identify vaccine candidates of Haemonchus
contortus and use them in a vaccine trial. This was done through protein binding assays
(western blots), candidate identification, epitope mapping assays, and in vivo vaccine trial
which included analysis of efficacy via parasitological parameters and molecular assays.
As populations across the globe increase, access to nutritious food also needs to
increase. Agricultural industries are working alongside scientists to try to make growing
food and livestock as efficiently as possible. Climate change is one of the largest threats
to agricultural industry. Changing climates make growing food more difficult as climate
disasters including floods, droughts, fires, and storms become more severe, more
frequent, and more difficult to predict. In the sheep industry, increased world temperatures
and humidity across the globe make Hc infections more likely to be an issue in areas
where it wasn’t before. As mentioned throughout, Hc is one of the greatest threats to the
sheep industry. Hc infections lead to decreased productivity of sheep, and increased
costs in lost lambs and treatments. Therefore, an increase in the number of regions that
Hc thrive would be devastating for the sheep industry, those that rely on lamb for income,
and those that rely on lamb meat for nutrition.
A major issue surrounding Hc is its ability to develop resistance to multiple
anthelmintic drugs. One method to combat Hc is the development of a vaccine. Although
BarberVax exists, it requires multiple boosters. This not only increases cost, but also
requires extensive time to administer the vaccine. BarberVax is composed of multiple
native antigens, meaning they are extracted from adult Hc homogenate. Thus far, there
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have not been successful protocols for growing adult Hc in vitro from egg stage. This
means that lambs and sheep are continuously infected and sacrificed to maintain
populations of Hc for protein extraction. To reduce the need for sheep in the chain of
vaccine production, one of the goals of this study was to identify a protein that could be
produced synthetically.
Limiting Factors
Vaccine trials designed to prevent Hc in sheep have been largely unfruitful. Some
of the difficulties associated with sheep studies include host specific studies, antigen
identification, and antigen production. Unlike mice used in initial vaccine studies, sheep
are largely outbred. This is both a positive and a negative. Because they are outbred,
they are more representative of sheep populations. However, having inbred animals and
the tools to produce inbred animals makes studying specific functions of a particular
molecule on a whole system more achievable. Another factor that contributes to the lack
of advances in sheep studies has been the lack of sheep-specific products, such as
antibodies specific for sheep proteins. However, in recent years, these products have
become increasingly more available. These issues are also applied to the search of
molecular based products specific to Hc.
Another limiting factor of studying Hc in its host is the availability of sheep; the
gestation period of a sheep 147 days and the weaning generally occurs at 60 days after
birth before a lamb can be used in an experiment (Sheep Production and Management:
reproduction in sheep). Most sheep are bred once a year and produce an average of 1.3
live lambs per ewe (USDA–APHIS–VS–CEAH–NAHMS, 2014). This largely limits the
amount of time in which an experiment can be performed and has the potential to limit
106

the number of sheep available for use. Alternative animal models of Hc infection to test
responses before using sheep are available but not practical. Jirds are gerbil- like animal
that can host Hc infections, but the parasite does not develop past L4 and establishment
of the parasite is too low for experimentation. Also, without complete development, eggs
would not be shed in the feces, thus monitoring infections would be difficult (Conder et
al., 1992).
Another concern in sheep studies is the use of the animal after it is sacrificed. H.
contortus infection does not prevent sheep from being used as food. In a normal infection
experiment with Hc, the animals would be sacrificed and could be butchered for profit and
food. Depending on the treatment, there is a withdrawal period between when an animal
is vaccinated or medicinally treated and when it can enter the food system. In terms of
vaccine experiments, novel components may not have been evaluated for their effect on
meat quality or safety. When these animals are sacrificed, their carcass cannot be used
for food and thus, these experiments may be less attractive and lucrative to some
researchers.
Explorations and Future Directions
Research originating in our lab showed that both SUF and STC antibody bound L3
better than XL3 and L4s based on larval binding assays. One of the main differences
between these life stages is the intact L3 cuticle of the L3 stage (Garza et al., 2017). This
led to the studies working to identify Hc antigens recognized by either SUF or STC
antibodies. We hypothesized that there were antigen(s) found in L3 cuticles that
contributed to an early immune response. St. Croix are known to be resistant to Hc
infection. It was unsurprising to find STC antibody bound more proteins and had more
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intense band development. However, the intensity of IgG binding of 35 kDa band was
unexpected. Whatever proteins were part of the 35 kDa band were not bound by Suffolk
IgG.
To ensure that the high binding results of the St. Croix immunoblot compared to
the Suffolk blot were not due to more antibody in the St. Croix serum, ELISAs were run
to measure antibody in the serum. The first ELISA performed was total ovine
immunoglobulin. These results showed that the Suffolk had significantly more total
immunoglobulin than the St. Croix (19.417 mg/ml vs 15.8317mg/ml, respectively). While
this measured total immunoglobulins, ELISAs were also performed to comparatively
measure H. contortus- specific IgG in each serum sample used in the immunoblot. Once
again, Suffolk serum had significantly higher levels of IgG towards Cuticle, L3, and Xl3(the
targeted antibody used in the immunoblot) than the St. Croix. These results indicate that
although the Suffolk had a more antibody towards the proteins, they were not as highly
specific to proteins as St. Croix IgG. These results led us to hypothesize that although the
Suffolk can produce antibody towards larvae homogenate, they may not be identifying
proteins that lead to protection. These results also are indicative that antibodies produced
by Suffolk may not be protective.
The 35 kDa band was excised and sent for mass spec identification. Before
proteins are analyzed with mass spectrometry, they are digested with different enzymes
to cut the protein into smaller peptides at certain amino acids. After digestion with trypsin,
the peptides were analyzed via mass spectrometry based on their size and charge.
Mascot database was used to identify the proteins and Scaffold (a proteome software)
was used to validate the identities. Based on the protein identification report received from
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University of Nebraska- Lincoln, “Peptide identifications were accepted if they could be
established at greater than 80.0% probability by the Peptide Prophet algorithm with
Scaffold delta-mass correction(Keller et al., 2002). Protein identifications were accepted
if they could be established at greater than 99.0% probability and contained at least 2
identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm
(Nesvizhskii et al., 2003).”
The analysis identified the 35 kDa protein as tropomyosin domain containing
protein (GenBank: CDJ92091.1). Further investigation of tropomyosin domain containing
protein using the BLAST feature of NCBI showed strong overlapping of Hc tropomyosin
domain containing protein with other invertebrate tropomyosin. These results led to
studying the protein as a potential vaccine candidate. In other invertebrate species,
tropomyosin has been identified as a main allergen (shellfish and cockroaches) and has
been investigated as a vaccine antigen for other species such as the red poultry mite,
ticks, and other parasites (Taylor et al., 1996; Hartmann et al., 1997; Cao and Liu, 1998;
Reese et al., 1999; Ayuso et al., 2002; Sereda et al., 2010; Wai et al., 2014).
However, the mass spectrometry results provided a list of 198 other proteins that
the band could contain. Most of the proteins identified during mass spec were not 35 kDa,
which reduced the number of proteins investigated during these experiments. The list of
proteins identified also means that although tropomyosin has been identified as an
antigen of other species, the other proteins may have been bound by sheep IgG in the 35
kDa band. A western blot was performed using anti- Charybdis feriata tropomyosin
antibody to bind Hc tropomyosin in the protein sample and confirm its presence at the
correct molecular weight after protein separation. These results did show that
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tropomyosin was there. While we were able to visualize tropomyosin via western blot, we
were not able to visualize the specific location of tropomyosin within the larval body.
Identifying the location of tropomyosin within different life staged of Hc will be key
if this protein is to be used in future vaccine experiments. Transmission electron
microscopy can be utilized to determine location of specific proteins within a biological
structure. This is done my labeling the protein with a metal, such as gold. The protein
labeled with gold-labeled antibody will appear as black dots against the rest of the
structure. Knowing the location of the protein within the structure will provide a better
understanding of whether the immune system has the potential to access to the protein
in vivo.
Several studies could be performed to confirm the identity of tropomyosin as an
antigen bound by STC antibody. These experiments could use synthetically produced
tropomyosin or tropomyosin isolated from HcL3 homogenate. In vitro produced-Hc
tropomyosin could be either bound to a plate for use in an ELISA, or the protein could be
bound by STC serum via western blot. These experiments could also be done using
native Hc tropomyosin isolated via pulldown column. This would be achieved by binding
anti-tropomyosin antibody to a column and eluting Hc protein through the column. This
would allow all other proteins to run through the column and Hc tropomyosin could then
be eluted from the specific antibody. Further, comparing antibody binding between in
vitro-produced tropomyosin or native tropomyosin could be valuable information for future
vaccine studies. These proteins could also be used to stimulate cells in vitro and compare
their abilities to induce proliferation.
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Further investigations of other potential vaccine antigens should utilize
immunoprecipitation assays. These assays use protein affinity, such as Protein A, of IgG
to immobilize antibody to a column (Sjöquist and Stålenheim, 1969). In terms of this
experiment, sheep antibody would be bound to a column and solubilized Hc protein would
be slowly passed through the column to allow antibody-antigen binding. After the
conjugates have bound, unbound protein can be washed through and the antibodyantigen complex can be eluted and antigens specifically bound by the antibody could be
identified. This also allows for different types of antigens to bind antibody, such as
glycogens, saccharides or lipids, not just proteins. Although this method requires multiple
steps, it would allow multiple antigens, again not just proteins, to be isolated at once.
Although tropomyosin was bound highly by STC IgG, we observed other proteins
bound by IgG and IgA that were not identified. To improve the efficacy of a future vaccine,
it would be imperative to identify other antigens bound by IgG and IgA. Increased levels
of IgA have been associated with lower fecal egg counts in sheep (Amarante et al., 2005;
Bowdridge et al., 2013; Hernández et al., 2016). Therefore, identifying IgA-bound
antigens has the potential to enhance the investigations of new putative vaccine
candidates.
This research focused on L3 of Hc because previous research has shown an ability
of St. Croix immune system to respond early in vivo, which would be to the L3. Also,
preventing L3 establishment would also prevent further development other life stages and
thus prevent infection. However, it may be more beneficial to target different life stages
either in addition to L3 or exclusively. Once they enter the abomasum, L3 or exsheathed
L3 move in and out of the lumen of the abomasum where they molt into L4 within two to
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three days. After 10 days post-infection, L4 develop buccal lancets that can then pierce
the lumen and release blood for consumption (Nicholls et al., 1985). These observations
mean that the L3 is not present as L3 for very long in the abomasum and thus targeting
other life stages may also be imperative to study. As mentioned, BarberVax targets adult
Hc enzymes that metabolize blood. Although BarberVax does not induce long-lasting
protection, it may be worthwhile to mix BarberVax with different adjuvants such as Alum
or oil-emulsion adjuvant to see if protection could be prolonged or enhanced after one
vaccination. It would also be advantageous to study and understand the correlates of
protection induced by BarberVax so that those units of the immune response could be
amplified to improve the vaccine.
Other research has found that there are other breeds of “resistant” sheep. The
mechanisms of resistance vary between these breeds. While not all mechanisms of
resistance have been elucidated, STC challenge experiments have shown that Hc are
unable to establish in the abomasum indicating a targeted immune response to L3.
Another resistant breed is Texel sheep. Studies measuring FEC and adult worm burden
after infection have shown reduced fecal egg count, but adult worms still establish in the
abomasum. After investigations, Garza and Weaver (unpublished data) showed that cells
mixed with antibody bound the genital pores of adult female Hc, blocking release of eggs
and reducing environmental contamination. These examples mean that different breeds
of resistant sheep immune systems may recognize different antigens. Therefore,
screening of these antigens via immunoblot or through column separation with different
breed serum could lead to many other vaccine candidates that should be explored.
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One of the most important future experiments include identification of antigenic
peptides. This study has the potential to provide multiple putative vaccine candidates.
Although it is understood that a Th2 response is necessary to provide protection against
H. contortus, more insight into what the immune system is recognizing or building an
adaptive response to would be illuminating. A series of experiments exploring not only
what antibody is binding, but what also what cells are recognizing have the potential to
reveal many unknown vaccine candidates. Understanding the differences in breed
immune responses could also benefit the sheep industry overall, as different resistant
breeds’ immune mechanisms are different from each other. This is apparent in the
previously discussed unpublished Garza and Weaver research showing different PBMC
and serum binding site preference between Texel and St. Croix. Collecting serum from
producers or other universities that have different resistant and susceptible breeds would
also provide an opportunity for further collaborations and new data. This experiment could
be achieved through an immunoblot with Haemonchus contortus protein separated via
gel electrophoresis followed by binding of different serums and finally a secondary
antibody and developer. This experiment could also be accomplished using a column that
binds sheep antibody followed by a flow through of H. contortus protein and finally
separation via gel electrophoresis.
Exploration of other vaccine candidates has the potential to identify more easily
producible proteins as well. As mentioned in chapter 3, production of tropomyosin domain
containing protein was attempted only to amplify a non-H. contortus gene after vector
insertion. However, if other vaccine candidates are identified and are smaller or better
documented, then they may be easier to produce in vitro. Selection of a protein that is
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easier to produce in vitro or having whole tropomyosin produced in vitro would also
eliminate the need to keep lambs infected for native protein, as they do with BarberVax.
Another advantage of recombinant proteins is that based on previous H. contortus
vaccine experiments recombinant proteins are more protective than peptides (Boisvenue
et al., 1991; Purcell et al., 2007; Kandil et al., 2017; González-Sánchez et al., 2018). This
is often the case, as peptides are small and need to be conjugated to a large carrier
protein to become more antigenic for vaccine use (Rappuoli et al., 2019). Whole
recombinant proteins also have an advantage of Determining the location of the peptides
within the protein structure provides information on the immune system’s ability to bind
these peptides used in the vaccine. Even if antibody is produced to the proteins, if they
are not accessible to the antibody, they would be worthless.
Another factor to consider during vaccination is the environment in which the
pathogen would be targeted by vaccine-induced antibody. In the case of H. contortus, the
parasite lives and is therefore targeted in a harsh environment- the abomasum or true
stomach. There, the pH highly acidic at a pH of 2-4. This low pH has the potential to
denature proteins or alter their confirmation. Antibody development after vaccination is to
the peptides (or protein in other cases) included in the vaccine. When released into the
abomasum, the low pH has the potential to alter the binding region of antibody, altering
its ability to bind its target protein. While our data showed that circulating antibody was
able to bind the vaccine peptides, these antibodies were isolated from blood, not the
abomasum. Therefore, in future experiments, it may also be beneficial to collect antibody
from the abomasal mucosa and determine its ability to bind its target. Understanding how
antibody binding is affected by pH could also be tested in vitro. Isolated serum could be
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incubated in different pH buffers and their binding capabilities could be tested in culture
with L3 or to peptides via ELISA.
Although Suffolk were able to produce antibody to the vaccine peptides, the
immune response induced by the adjuvant was not appropriate for protection against H.
contortus. Therefore, future vaccine experiments should include multiple adjuvants to
select the best in terms of this infection. As several studies have shown, resistant breeds
mount Th2 responses against Hc and thus, a Th2 response should be the goal of the
vaccine adjuvant. However, other studies have also shown low recruitment of neutrophils
early in the abomasum. Combined with recent finding that Suffolk neutrophils stimulated
with HcLA in vitro are able produce IL-4, these data suggest that an adjuvant that induces
cellular recruitment may be a positive addition to the vaccine (Middleton et al., 2020).
Previous studies have revealed an inability of Suffolk lambs and wool composite
lambs to produce an early Th2 response, like St. Croix sheep. Instead, high levels of
inflammatory genes are upregulated early and did not level off to allow a Th2 response
(Bowdridge et al., 2015; Shepherd, 2019). Gene expression of the abomasal lymph nodes
from this vaccine experiment animals showed that there was neither Th1 or Th2 response
induced by any of the treatments (vaccination or adjuvant only). However, the adjuvant
seemingly induced il17a gene expression. Il17a is a cytokine produced by Th17 cells
which are described as proinflammatory cells and has not been associated with reduced
parasitic infection. This adjuvant (Montanide ISA 61 VG) was chosen to induce both a
long-lived antibody response, but also to potentially increase the cellular response . Gene
expression from the infection only group did reveal an interesting increase in foxp3
expression, a gene associated with T regulatory cells. These data may suggest that the
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local lymph node environment may be preventing a switch to Th2 response. Selecting
adjuvants that induce a stronger Th2 response to overcome a consistent Th1 response
or Treg response may be a better adjuvant selection for future vaccine trials. Alum is a
common Th2-inducing adjuvant and could be used in future vaccine trials against Hc.
Alum has also been associated with increased recruitment of neutrophils, monocytes and
eosinophils (Calabro et al., 2011). These cell types are recruited to the site of infection
during an effective immune response against Hc and thus using Alum has the potential
to increase immunity during vaccination.
Further, while parasitological parameters are important in parasite vaccine trials, it
is also important to understand why the vaccine did or did not work. To understand the
results of the parasitological parameters, cell types, gene expression, and protein
abundance at the site of infection could all be indicators vaccine effectiveness. Therefore,
in a future vaccine trial, snap-freezing tissue for immunohistochemistry would provide an
opportunity to understand the local cytokine levels beyond gene expression. It will also
be important to understand the effects of the vaccine on meat quality and withdrawal
period- are there traceable amounts of the vaccine in the food parts of the carcass?
Without this knowledge, these vaccines would not be viable even if they were effective.
Conclusions
These studies have shown that there are large disparities between St. Croix and
Suffolk antibody development to specific Hc proteins during infection. While this is
unsurprising, an immunoblot showed how different antibodies produced by the different
breeds was; specifically, St. Croix IgG bound one Hc protein exceptionally well, while
Suffolk IgG did not bind it at all. This protein was identified as tropomyosin domain
116

containing protein. These results led to further investigations of specific antigenic epitopes
of this protein for a putative use in vaccine. Four new epitopes were chosen via epitope
mapping for a vaccine trial. Suffolk sheep were selected to use for this trial, as they are a
susceptible breed that would be the target of this vaccine in a production system. The
vaccine was composed of a cocktail of the four peptides from the epitope mapping
experiment and Montanide ISA 61 VG adjuvant. This water-in-oil adjuvant induces a
strong cellular response and long-lasting antibodies. Weekly antibody analysis showed
elevated levels of peptide-specific antibodies week two after vaccination and through the
end of the trial in the vaccinated sheep. However, the antibodies were not protective, as
all infected groups had statistically same fecal egg counts (weekly measures of infection)
and adult worm burdens. There was an adjuvant effect of increased il17a gene
expression. Increased IL-17A could have contributed to the lack of protection, as it is an
inflammatory cytokine. These results illustrate a need for experimenting with different
adjuvants to induce different immune responses. Although these experiments were not
successful in protecting the animals, they build a roadmap for future antigen discovery
and vaccine trial methods.
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